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ORAL PRESENTATIONS
1
Prognosis of small screen-detected invasive breast
cancers
I Ellis
Department of Histopathology, Nottingham City Hospital,
Nottingham, UK
Breast Cancer Res 2008, 10(Suppl 3):P1 (doi: 10.1186/bcr1999)
The emphasis of mammographic breast screening is to detect small
invasive breast cancers at a time in their natural history when early
detection and treatment will reduce significantly the risk of death.
However, breast screening cannot be absolutely specific in its
approach and detects a wide spectrum of breast cancer, ranging
from microfocal low-grade ductal carcinoma in situ to large high-
grade invasive cancer. It is well recognized that many of the low-
grade, special invasive cancers identified at screening have an
excellent prognosis but may be so indolent that they would never
have presented clinically or have threatened the life of the patients. It
has been proposed alternatively that a proportion of these low-grade
invasive tumours might, if not detected, de-differentiate over time into
more aggressive, less well-differentiated tumours. Identification and
removal of such cancers when they are at a low grade would avoid
such progression. Detection of high-grade invasive cancers when
they are small is clearly a means by which screening could reduce
breast cancer mortality; for example, the Two-County Trial in Sweden
has shown that histological grade 3 invasive cancers detected when
<10 mm have an excellent prognosis, while it is widely recognized
that large high-grade invasive cancers have a poor prognosis. In
addition, the presence of vascular invasion and lymph node
metastasis, which are associated with development of metastatic
disease, are rare in grade 3 tumours <10 mm, grade 2 tumours <10
mm and grade 1 tumours <20 mm, indicating that detecting tumours
under a certain size should be beneficial.
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Positron emission tomography in breast disease
B Sharma
The Royal Marsden Hospital, London and Surrey, UK
Breast Cancer Res 2008, 10(Suppl 3):P2 (doi: 10.1186/bcr2000)
Functional imaging techniques including positron emission tomo-
graphy/computed tomography (PET/CT) are now increasingly
being used for oncological patient management. Knowledge of the
strengths and weaknesses of this evolving technique is critical for
appropriate and optimal patient management. A state of the art
presentation is provided to demonstrate the role of PET/CT in
breast cancer, with a literature review and practical clinical patient
examples from our very extensive experience of imaging in breast
cancer.
Current PET/CT does not have a sufficiently high accuracy for the
diagnosis of primary breast cancer or for routine axillary nodal
staging. Worldwide literature and our own experience show the
converse to be true for metastatic breast cancer, PET/CT now
being recognised as the most accurate single imaging modality to
define/stage metastatic breast disease. The role of PET/CT in the
patient pathway, with specific comparison with triple assessment,
CT, magnetic resonance imaging and MDP bone scan is
addressed. The accuracy of PET/CT for evaluation of nodal,
visceral (including liver disease, brachial plexopathy and for
pre/post-radio-frequency ablation evaluation) and bony disease is
discussed. The important use of PET/CT for response assessment,
specifically for bone disease, and its use in guiding management
(re. hormone therapy, chemotherapy and radiotherapy) are high-
lighted. The development of more specific PET tracers, targeting
the oestrogen receptor, is also discussed.
Reference
1. Sharma B: Imaging in breast cancer. In  A Handbook of
Metastatic Breast Cancer. Edited by Johnston SRD, Swanton
C; 2007.
3
Ultra-small iron particle-enhanced magnetic resonance
imaging of axillary lymph nodes in breast cancer
TH Helbiech
Department of Medical Imaging, UHN/MSH/WCH, University of
Toronto, Princess Margaret Hospital, Toronto, Canada
Breast Cancer Res 2008, 10(Suppl 3):P3 (doi: 10.1186/bcr2001)
Objective To report the diagnostic value of ultra-small iron particle
(USPIO)-enhanced magnetic resonance imaging (MRI) in the
detection of axillary lymph node metastases in patients with breast
carcinomas.
Methods  Patients with breast carcinomas were enrolled in a
prospective phase III study. MRI of the axilla was performed at 1
Tesla prior to and 24 to 36 hours after intravenous administration
of USPIO (Sinerem®; Guerbet, France). MRI sequences were
performed pre and post USPIO administration (axial T1 3D FFE,
axial and sagittal T2* FFE, and T2 TSE). Imaging results were
compared with histopathologic findings.
Results A total of 154 lymph nodes were detected equally by pre
and post USPIO-MRI. USPIO-MRI revealed a node-by-node
sensitivity, specificity, and accuracy of 92%, 99%, and 98%,
respectively. USPIO-enhanced MRI did not miss any lymph node
metastases in a patient-by-patient correlation.
Conclusion USPIO-MRI is a valuable method in the assessment of
axillary lymph node metastases in patients with breast carcinomas
and has potential as a noninvasive sentinel lymph node technique.S2
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Ultrasound elastography
G Rizzatto
General Hospital, Via Vittorio Veneto, Gorizia, Italy
Breast Cancer Res 2008, 10(Suppl 3):P4 (doi: 10.1186/bcr2002)
Real-time elastography (RTE) of the breast is accurate and
reproducible, and may easily and quickly integrate conventional
ultrasound and other breast imaging.
We use a new five-step score that modifies the original Tsukuba
classification. In fact, this last score is related only to solid lesions
while the BI-RADS Breast Imaging Reporting and Data System
considers also nonsolid lesions; in our practice we observed that
the cysts always show a typical three-layered pattern.
This pattern is due to an artifact. With RTE scanning, many
elasticity images are obtained by comparing two adjacent frames
to evaluate the displacement generated by the probe with
continuous compression and relaxation movements. The displace-
ment of these two adjacent frames is usually small (<0.5 mm). The
echo intensity inside the cyst is extremely low. The displacement at
the center is erroneously estimated as almost 0 and is represented
as a green band. The two areas near the cystic wall have a different
displacement value, with a strain that is lower in the front (blue)
and higher in the back (red). 
RTE shows a very high specificity in benign lesions, including BI-
RADS category 3 lesions. With the best cutoff point between
elasticity scores 3 and 4, the negative predictive value is around
98%. RTE works better with small lesions. RTE is insensitive to the
thickness and the echogenicity of the breast, and to the depth and
the size of the lesion.
RTE scores are well reproducible. Indexes of intra-observer (κ =
0.93) and inter-observer (κ = 0.90) agreement are very good.
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Minimising surgical treatment of early breast cancer
R Rainsbury
The Royal Hampshire County Hospital, Winchester, UK
Breast Cancer Res 2008, 10(Suppl 3):P5 (doi: 10.1186/bcr2003)
Introduction Breast-sparing oncoplastic procedures (BSOP) offer a
radical new alternative to mastectomy and conventional breast-
conserving surgery in early breast cancer treatment. Wider clearance
reduces local recurrence, with a direct impact on long-term survival
[1]. Loss of volume is the leading cause of breast deformity,
especially for central, medial and inferior tumours [2]. BSOP require
the simultaneous deployment of oncological and reconstructive
skills, and the emergence of oncoplastic surgeons is increasing the
availability of these procedures in clinical practice [3].
Indications BSOP are most appropriate when resecting 20% to
50% of the breast volume [4], when the likelihood of major
deformity escalates [2]. New assessment tools enable direct
calculation of the volume loss [2], and this approach is proving a
useful alternative to total mastectomy and immediate recon-
struction in patients requiring postmastectomy radiotherapy [5].
These techniques allow extremely wide local excision while
minimising the sensory and structural disturbance following total
mastectomy [6]. The techniques avoid the sequelae of implant-
based procedures and enjoy the benefits of autologous recon-
struction.
Choice of technique BSOP encompass two fundamentally
different approaches. Firstly, volume displacement techniques,
which transpose local breast flaps into the resection defect and
are most suitable for medium to large, ptotic breasts. Secondly,
volume replacement techniques, which transpose autologous
tissues from extramammary sites, and are most suitable for women
with small to medium-sized breasts who wish to avoid volume loss.
Both techniques adapt conventional methods of breast reduction
or reconstruction to avoid the need for mastectomy, and a variety
of volume displacement and volume replacement techniques have
been described [7].
Outcomes  For volume displacement, 11 retrospective studies
involving 433 patients have reported local recurrence rates of 0%
to 7% and cosmetic failure rates of 0% to 18% at a median follow-
up of 21 to 54 months. For volume replacement, seven studies
involving 189 patients have reported local recurrence rates of 0%
to 5% and cosmetic failure rates of 0% to 9%, with a median
follow-up of 24 to 53 months [7]. The clinical utility of BSOP
awaits further assessment and the wider availability of oncoplastic
skills [8].
References
1. Early Breast Cancer Trialists’ Collaborative Group: Lancet
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2. Cochrane RA, Valasiadou P, Wilson ARM, et al.: Br J Surg
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Minimising oncological treatment of early breast cancer
J Yarnold
Academic Radiotherapy Unit, Royal Marsden NHS Trust, Sutton, UK
Breast Cancer Res 2008, 10(Suppl 3):P6 (doi: 10.1186/bcr2004)
Recommendations for adjuvant systemic therapies are based on
estimates of life expectancy (prognostic markers) and of benefit to
therapy (predictive markers). The oestrogen receptor is a classic
predictive marker guiding use of anti-oestrogen therapy, and
expression profiling appears to select patients more or less likely to
benefit. Expression profiling is also under evaluation as a
prognostic marker to identify patients who do not need cytotoxic
chemotherapy (MINDACT trial). Biological therapy with trastuzu-
mab is prescribed on the basis of a predictive test for over-
expression of the target growth factor receptor protein, HER2. The
ER- PR- HER2- subgroup identifies patients who may benefit
selectively from platinum compounds. In radiotherapy, there is also
a trend towards delivering fewer, larger fractions of breast
radiotherapy to a lower total dose than the historical standard 50
Gy in 25 fractions. Partial breast radiotherapy is under test as a
safe and effective alternative to whole-breast radiotherapy for
women with low-risk disease, a measure that is also likely to
reduce iatrogenic morbidity in long-term survivors. Finally, the
identification of subgroups in which radiotherapy can be safely
withheld remains a research priority, with age as the single most
powerful factor predicting risk of local relapse.S3
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Promoting early presentation of breast cancer
AJ Ramirez
Cancer Research UK London Psychosocial Group, King’s College
London, UK
Breast Cancer Res 2008, 10(Suppl 3):P7 (doi: 10.1186/bcr2005)
Amongst patients with breast cancer there is strong evidence that
delays in excess of 3 months between onset of symptoms and
diagnosis/treatment are associated with worse survival rates than
shorter delays. The predominant risk factors for patient delays in
breast cancer include lack of awareness that breast symptoms
could be due to cancer and lack of awareness of personal risk.
Ideally an intervention to reduce delayed presentation of breast
cancer would promote early help-seeking behaviour by patients at
high risk of having cancer, but would not promote anxiety amongst
people at low risk. It is important that patients should not be made
unnecessarily anxious, and nor should general practitioners be
overburdened with consultations with the worried well population.
Based on the empirical evidence for the risk factors for patient
delay and using effective behavioural change techniques, we have
developed and are evaluating a psycho-educational intervention to
promote early presentation of breast cancer by older women. We
have focused our intervention on older women who are at greater
risk of breast cancer and are also more likely to delay their
presentation. The intervention is delivered by trained diagnostic
radiographers at the point when the women leave the routine
protection afforded by the National Health Service Breast Screen-
ing Programme and is in line with government recommended
practice and complementary to the Breast Screening Programme.
The ultimate aim of the intervention is to reduce the proportion of
older women with breast cancer who delay their presentation, and
thereby save lives.
I will outline this work and other current initiatives within the United
Kingdom to promote awareness and early presentation of breast
cancer and how these might inform the development of policy
initiatives to improve outcomes for patients within the National
Health Service.
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Magnetic resonance imaging of ductal carcinoma in situ
C Kuhl
Department of Radiology, University of Bonn, Germany
Breast Cancer Res 2008, 10(Suppl 3):P8 (doi: 10.1186/bcr2006)
Intraductal cancer or ductal carcinoma in situ (DCIS) has been
considered a mammographic disease. Before the advent of
mammographic screening, only about 2% to 5% of breast cancers
were diagnosed in the intraductal stage. Magnetic resonance
imaging (MRI) has traditionally been considered insensitive for
DCIS. More recent studies, however, suggest that, with
appropriate diagnostic criteria, contrast-enhanced MRI may be a
very sensitive tool for diagnosing DCIS, especially high-grade
DCIS. In addition, MRI has been shown to be superior to delineate
the intraductal extension of invasive cancers – another reason why
preoperative staging with MRI is important. The likelihood with
which the mammographic diagnosis of DCIS or DCIS components
fails does not correlate with mammographic breast density – in
other words, a missed mammographic diagnosis of DCIS is also
conceivable in women with involuted breast. The present lecture
summarizes the current level of evidence, and discusses the
clinical implications of these findings.
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Introduction to proton (1H) magnetic resonance
spectroscopy of the breast
L Bartella
Eastside Diagnostic Imaging, Manhattan, New York, USA
Breast Cancer Res 2008, 10(Suppl 3):P9 (doi: 10.1186/bcr2007)
Proton magnetic resonance spectroscopy (1H MRS) provides
biochemical information about the tissue under investigation. The
diagnostic value of 1H MRS in cancer is typically based on the
detection of elevated levels of choline compounds, which is a marker
of active tumor [1]. Breast 1H MRS is performed on a clinical magnet
of 1.5 T or higher in field strength. A four or more channel breast coil
is also needed, just as for imaging. The most widely used technique
is the single voxel technique, which is limited to scan one lesion at a
time. Magnetic resonance spectroscopic imaging provides
information about the spatial distribution of metabolites and is useful
for studying multiple lesions [2,3]. The two main potential clinical
applications of 1H MRS include its use as an adjunct to breast MRI
to improve the specificity in differentiating benign from malignant
lesions and in monitoring or even predicting response to treatment in
patients undergoing neoadjuvant chemotherapy. Studies have
suggested that 1H MRS may decrease the number of benign
biopsies recommended by MRI [4,5]. Also, in patients undergoing
neoadjuvant chemotherapy, 1H MRS may be able to predict
response as early as 24 hours after the first dose [6]. Currently,
several limitations exist that make the technique premature for clinical
use [7]. Preliminary data are promising, warranting further evaluation
with larger, preferably multicenter, trials.
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Magnetic resonance imaging in breast cancer: results of
the COMICE trial
L Turnbull
Centre for MR Investigation, Hull Royal Infirmary, Hull, UK
Breast Cancer Res 2008, 10(Suppl 3):P10 (doi: 10.1186/bcr2008)
The role of the addition of magnetic resonance imaging (MRI) to
routine techniques for locoregional staging of primary breastS4
cancer is unclear. The COMICE trial considered whether adding a
MRI scan to conventional triple assessment (mammogram, ultra-
sound and biopsy) assisted locoregional staging, and thereby
reduced reoperation rates, for patients with primary breast cancer
scheduled for wide local excision.
The primary endpoint of the COMICE trial considered the propor-
tion of patients undergoing a repeat operation or mastectomy at
further surgery within 6 months of randomisation, or an avoidable
mastectomy at initial surgery (reoperation rate). This was compared
using logistic regression adjusting for age, breast density, and
surgeon.
Between December 2001 and January 2007, 1,625 patients were
randomised to receive MRI (n  = 817) or not (n  = 808). The
reoperation rate within 6 months (primary outcome) was 18.8%
(MRI) and 19.3% (no MRI). No significant difference between the
arms was detected (odds ratio = 0.96, 95% CI = (0.75, 1.24), P =
0.7691). Secondary endpoints included quality of life, imaging
effectiveness and local recurrence.
The results of the COMICE trial indicate no significant benefit in
terms of reduction in reoperation rates by the addition of MRI to
conventional triple assessment for this patient group. These results
have importance from both health economic and patient burden
perspectives.
Acknowledgement The project was funded by the NIHR Health
Technology Assessment (HTA) Programme (Project Number
99/27/05) and will be published in full in a HTA report. The view
and opinions expressed therein are those of the authors and do not
necessarily reflect those of the Department of Health.
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Three-dimensional mammography
MJ Yaffe
Imaging Research Program, Sunnybrook Health Sciences Centre,
University of Toronto, Canada
Breast Cancer Res 2008, 10(Suppl 3):P11 (doi: 10.1186/bcr2009)
The contribution of screening mammography to reducing mortality
due to breast cancer in women over 40 years old has been clearly
demonstrated. Nevertheless, film mammography has several
technical limitations that diminish its performance in women with
dense breasts. Digital mammography goes part of the way to
overcoming these limitations, but its diagnostic accuracy can still
be impaired by superposition of fibroglandular structures at
different levels within the breast. It may be possible to improve
sensitivity and specificity further by producing tomographic images
of the breast through one of two new techniques, tomosynthesis or
breast computed tomography. Tomosynthesis can be carried out
on a modified digital mammography system in which the X-ray tube
can be rotated about the breast to obtain a number of projection
views over a range of different angles. The images are obtained
from these projections by mathematical reconstruction. Computed
tomography requires a dedicated gantry that allows a full rotation
of the X-ray beam about the pendant breast as the woman lies
prone on a table. Each of these imaging methods isolates
structures within the breast, potentially making tumours and
microcalcifications more conspicuous. Each technique has its
strengths and weaknesses with respect to radiation dose and
various aspects of image quality, and these will be discussed in the
current presentation. In addition, trials underway to evaluate the
techniques’ performance will be described.
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CADET 2 results/computer-aided detection update
F Gilbert
University of Aberdeen, UK
Breast Cancer Res 2008, 10(Suppl 3):P12 (doi: 10.1186/bcr2010)
Computer-aided detection (CAD) systems that attract the reader’s
attention to potentially suspicious features on a mammogram are
now in clinical use in screening mammography in the USA and
some European countries. However, recent publications have
debated the benefit of CAD systems in screening mammography
and have highlighted the need for robust evidence from pros-
pective randomised trials. The evidence from these studies will be
reviewed, including a recently published meta-analysis of double
reading versus single reading with CAD.
The CADET II trial was a prospective multicentre randomised
comparison of single reading with CAD and double reading in the
UK National Health Service Breast Screening Programme. Over
30,000 women (age 50 to 70 years), attending routine mammo-
graphy at three UK breast screening centres, were recruited into
the trial. Film batches from screening sessions were randomly
assigned in a ratio of 28:1:1 to one of three film-reading regimes:
double reading and single reading with CAD, or double reading
only, or single reading with CAD only. The primary outcome
measures were matched comparisons of the cancer detection
rates and the number of women recalled for assessment by the
two reading regimes. The results of the study will be presented at
the conference. The implications of this study will be discussed
together with further work that needs to be undertaken.
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Contrast enhanced and dual energy mammography
MJ Yaffe
Imaging Research Program, Sunnybrook Health Sciences Centre,
University of Toronto, Canada
Breast Cancer Res 2008, 10(Suppl 3):P13 (doi: 10.1186/bcr2011)
Occasionally, a lesion is missed on mammography either because
it lies within a region of dense surrounding breast tissue or
because its X-ray absorption appears to be almost identical to that
of the adjacent tissue. In breast magnetic resonance imaging,
images acquired pre and post administration of an intravenous
contrast agent (Gd DTPA) are subtracted to reveal pooling and
washout of this agent in the presence of tumour angiogenesis,
which occurs as a growing tumour recruits the development of
new blood vessels. Breast magnetic resonance imaging has been
shown to be much more sensitive than mammography in certain
groups of young, high-risk women. It is possible to exploit this
phenomenon using a much less costly and more accessible
approach through contrast-enhanced digital mammography. Here,
a nonionic iodine contrast agent is injected between pre and post
contrast image acquisitions in which the X-ray beam is produced at
a relatively high energy, above the K-edge of iodine. The images
are subtracted, cancelling the soft-tissue contrast that is common
to the two images and isolating the iodine signal in the region of
angiogenesis. A series of post-contrast images can be obtained to
track the kinetics of the uptake and washout. These images and
the morphology of the lesion can reveal the presence,
characteristics and extent of disease. Dual-energy approaches to
improve speed or a combination of contrast imaging with tomo-
synthesis to provide three-dimensional images are also possible.
The concept of this technique will be presented and some clinical
cases will be shown.
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Lesion size is a major determinant of the mammographic
features of ductal carcinoma in situ: findings from the
Sloane Project
A Evans1, K Clements2, A Maxwell3, H Bishop3, A Hanby4, 
G Lawrence2, O Kearins2, S Pinder5
1Breast Institute, Nottingham City Hospital, Nottingham, UK; 2West
Midlands Cancer Intelligence Unit, Birmingham, UK; 3Breast Unit,
Royal Bolton Hospital, Bolton, UK; 4Leeds Teaching Hospitals
NHS Trust, Leeds, UK; 5King’s College London, UK
Breast Cancer Res 2008, 10(Suppl 3):P14 (doi: 10.1186/bcr2012)
The present study aims to assess the influence of lesion size on
the radiological features of screen-detected ductal carcinoma in
situ (DCIS) in Sloane Project cases.
Cases where calcification was present mammographically, and
histological grade and size were available, were included. Calcific
DCIS was classified radiologically as casting/linear, granular/
irregular or punctate. The pathology dataset included tumour grade
and size. Correlations were sought between the radiological and
pathological findings and significance assessed.
A total of 1,783 cases were included. Of these, 1,128 women,
485 women and 170 women had high-grade, intermediate-grade
and low-grade DCIS, respectively. Casting calcification was more
frequently seen the higher the tumour grade; occurring in 58% of
high-grade, 38% of intermediate-grade and 26% of low-grade
cases, respectively (P  < 0.001). However, casting calcification
was also increasingly common with increasing size, irrespective of
grade (P < 0.001). Thus casting calcifications in small (<10 mm)
high-grade DCIS were seen with a similar frequency (50%) to
those in moderate-sized (21 to 30 mm) intermediate-grade lesions
(48%) and to those in large (>30 mm) low-grade lesions (46%).
Lesion size has a strong influence on the radiological features of
calcific DCIS; small high-grade lesions often show no casting
calcifications, while casting calcifications are seen in approaching
one-half of large low-grade lesions. The radiological appearances
alone cannot be used to predict the histological grade of DCIS.
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Evaluating tumour response to primary
radiochemotherapy in breast cancer patients: what role for
breast magnetic resonance imaging?
F Thibault, MA Bollet, A Tardivon, C Malhaire, 
G Zemmour-Elfersi
Institut Curie, Paris, France
Breast Cancer Res 2008, 10(Suppl 3):P15 (doi: 10.1186/bcr2013)
Objective To evaluate the accuracy of clinical examination and of
three imaging modalities (mammography, ultrasound, and magnetic
resonance imaging (MRI)) to assess the tumour response to a pre-
operative regimen of concurrent radiochemotherapy for large
breast cancers, and to anticipate the eventual complete pathologic
response.
Methods Sixty breast cancer women not amenable to conserving
surgery at initial presentation were accrued in a phase II study.
Treatment consisted of four cycles of 5-fluorouracil–vinorelbine
with, starting with the second cycle of chemotherapy, radiotherapy
to the breast and regional lymph nodes. Breast-conserving surgery
or mastectomy was performed 4 to 6 weeks after completion of
irradiation. Imaging assessment was performed before chemo-
therapy and preoperatively.
Results Referring to pathologic data, the MRI assessment
performed best. A 50% or greater decrease in the largest tumour
diameter in MRI was linked to complete pathologic response with
81% sensitivity and 75% specificity. MRI–pathologic correlations
helped understand the pitfalls in MRI interpretation that led to
overestimating/underestimating some tumour responses.
Conclusion Compared with the other assessment modalities, MRI
substantially improved the prediction of pathologic tumour
response. Pitfalls or limits in MRI interpretation in this specific
setting were better understood.
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Evaluation of the diagnostic value of high temporal and
spatial resolution morphologic, dynamic, spectroscopic
and diffusion-weighted magnetic resonance imaging in
patients with breast lesions at 3 T
K Pinker1, W Bogner1, S Gruber1, P Szomolanyi2, G Grabner1,
G Heinz-Peer3, T Helbich4, S Trattnig1
1MR Centre of Excellence, Department of Radiology, Medical
University Vienna, Austria; 2Department of Imaging Methods,
Institute of Measurement Science, Slovak Academy of Sciences,
Bratislava, Slovakia; 3Department of Radiology, Medical University
Vienna, Austria; 4Department of Medical Imaging, University of
Toronto, Canada
Breast Cancer Res 2008, 10(Suppl 3):P16 (doi: 10.1186/bcr2014)
Introduction To evaluate the diagnostic value of combined high
temporal and spatial resolution morphologic, dynamic, 1H-spectro-
scopic (3D-MRSI) and diffusion-weighted magnetic resonance
imaging (MRI) in patients with breast lesions at 3 T using histology
as the gold standard.
Materials and methods Fifteen patients were examined on a 3 T
system using a four-channel breast coil. The MRI protocol
included: contrast-enhanced (CE) coronal volumetric interpolated
breathhold examination with high temporal resolution (isotropic
1.7 mm, time of acquisition (TA) 11.7 seconds, 17 measurements);
coronal magnetization prepared rapid gradient echo at expected
maximum CE (1 mm isotropic, TA 2.03 minutes); repeated coronal
volumetric interpolated breathhold examination, twice-refocused
singleshot echo planar imaging sequence with inversion recovery
fat-saturation employing four b values (TA 4.48 minutes), 3D-MRSI
( 1 0x1 0x1 0m m 3; TA 11 minutes). The lesion morphology was
assessed. Regions of interest for suspicious areas were labelled
manually and evaluated for elevated choline levels, decreased
apparent diffusion coefficient (ADC) values and CE kinetics.
Results  Twenty-seven lesions were detected in 15 patients.
Eleven lesions were diagnosed as malignant due to morphology,
CE, elevated choline levels and lowered ADC values and were
confirmed by histology. Sixteen lesions demonstrated monophasic
or biphasic enhancement curves and no elevated choline levels or
lowered ADC values, and proved to be benign by histology.
Conclusion  Combined high temporal and spatial resolution
morphologic, dynamic, spectroscopic and diffusion-weighted MRI
of the breast provides morphologic, kinetic, metabolic and
functional information of breast lesions and is a valuable tool for
differentiation of benignity and malignancy.
Available online http://breast-cancer-research.com/supplements/10/S3S6
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Ultrasound-guided axillary node core biopsy in the staging
of newly diagnosed breast cancer
P Britton1, A Goud1, S Barter1, A Eleti1, A Freeman1, 
M Gaskarth1, P Moyle1, P Rajan1, R Sinnatamby1, J Slattery1, 
E Provenzano1, S Pinder2, S Godward3, G Wishart1
1Cambridge Breast Unit, Cambridge, UK; 2Department of
Pathology, Guy’s King’s Thomas’s Hospital London, UK;
3Cambridgeshire Primary Care Trust, Cambridge, UK
Breast Cancer Res 2008, 10(Suppl 3):P17 (doi: 10.1186/bcr2015)
One hundred and thirty-nine patients with core biopsy (CB)-proven
unilateral primary operable invasive breast cancer underwent
axillary ultrasound. Lymph nodes were identified on ultrasound in
134 patients (96%), of which 121 (87%) underwent core biopsy.
The morphology of all biopsied nodes was noted. Normal lymph
node was obtained in 77 CBs, 25 (32%) of which were
subsequently shown to have nodal metastases. The results are
presented in Table 1. The CB sensitivity for nodes with normal
ultrasound morphology was 12%, for those with unilobulated
cortex was 64%, for those with multilobulated cortex was 77%, for
those with absent hilum was 88% and for those with multilobulated
cortex and absent hilum was 100%.
In conclusion, the present study shows that an aggressive CB
policy leads to an increase in sensitivity, but of relatively modest
proportions, and is at the expense of a large number of normal
biopsies. CB is insensitive at detecting micrometastases. CB of
nodes with a normal ultrasound morphology is of little utility.
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Medico-legal issues in breast imaging
HN Purushothaman1, JC Morel1, E O’Flynn1, ARM Wilson1,2, 
MJ Michell1
1King’s College Hospital NHS Trust, London, UK; 2Guy’s and St
Thomas’ Hospitals NHS Foundation Trust, London, UK
Breast Cancer Res 2008, 10(Suppl 3):P18 (doi: 10.1186/bcr2016)
Objective To identify medicolegal issues that occur in the diagnosis
and radiological management of breast disease. To propose
measures to reduce the risk of patient complaints and legal action.
Methods A retrospective study was undertaken and records of 40
medicolegal investigations over a 4-year period were examined
(January 2004 to December 2007). The reports were compiled by
two consultant breast radiologists who are recognised experts in
the field of breast diagnosis.
Results Thirty per cent of the patients in this study were <40 years
of age. The most common complaint in this series was a delay in
diagnosis (90%). The mean average delay in diagnosis was 17.3
months. Substandard care was cited in 60% cases, of which 66%
was considered the fault of the radiologist involved. Of these cases
67% of mammograms were reported as normal or of benign
features, with microcalcification being the most common mammo-
graphic sign to be missed or misinterpreted (75%).
Conclusion The commonest complaint is delay in diagnosis. Com-
plaints are more common in the younger age group, consistent
with the previous American Breast Cancer Study [1]. Micro-
calcification was the commonest sign in cases where there was
incorrect interpretation of the radiology.
Reference
1. Physician Insurers Association of America: Breast Cancer
Study. Washington, DC: Physician Insurers Association of
America; 1995.
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Objective To develop and pilot a training programme for
radiographers to deliver a psycho-educational intervention to
women receiving their final invited mammogram with the National
Health Service Breast Screening Programme (NHSBSP).
Background A 10-minute structured interview has been
developed and tested, which aims to improve older women’s
knowledge about breast symptoms and personal risk, and to
increase confidence to detect a breast change. The intervention is
quality assured against competency ratings on the content and
style of the interview.
Training model Includes didactic teaching, communication skills
training, experiential learning using role-play with actors and
feedback on videotaped interviews. Skills are rehearsed in a clinic
setting with mentoring from trained radiographers.
Evaluation Feasibility of training in the NHSBSP was tested with
four radiographers working in the South East and South West
London breast screening services. Competence and confidence to
deliver the interview were assessed before and after training.
Results All four radiographers completed the training programme.
Three of the four radiographers were assessed as competent and
all increased their confidence to deliver the intervention.
Conclusion  It is feasible to train diagnostic radiographers to
reliably deliver an intervention to promote early presentation of
breast cancer, and thereby potentially save lives.
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Two systematic reviews to compare effects of double
reading and computer-aided detection on both cancer
detection and recall rate
PM Taylor, HWW Potts
University College London, UK
Breast Cancer Res 2008, 10(Suppl 3):P20 (doi: 10.1186/bcr2018)
There are two competing methods for improving the accuracy of a
single screening radiologist: use of a computer aid (CAD) or
double reading.
Bibliographic databases were searched for studies where either
intervention was incorporated into routine screening work. Meta-
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Table 1 (abstract P17)
Number of axillas examined 139
Number of axillas where nodes identified on ultrasound 134 (96%)
Number of axillas where CB performed 121 (87%)
CB inadequate rate (%) 4.1
Lymph node-positive (surgery) (%) 52.5
CB sensitivity, all positive nodes (%) 53.4
CB sensitivity, macrometastases (%) 62.3
CB sensitivity, micrometastases (%) 8.3S7
analyses were performed to find overall estimates of the impacts of
CAD and double reading on both the cancer detection rate and
the recall rate.
Ten studies were found comparing single reading with CAD to
single reading. Seventeen studies were found comparing double
reading to single reading. Double reading generally increases the
cancer detection rate, but also the recall rate. However, double
reading with arbitration increases the detection rate (95% CI =
1.02 to 1.15) and decreases the recall rate (95% CI = 0.92 to
0.96). CAD does not have a significant effect on the cancer
detection rate (95% CI = 0.96 to 1.13) and increases the recall
rate (95% CI = 1.09 to 1.12). However, there is considerable
heterogeneity in the impact on the recall rate in both sets of
studies.
There is better evidence for an improvement in the cancer detec-
tion rate with a human second reader than with CAD. Arbitration
where two readers disagree also delivers a reduced recall rate,
whereas CAD increases the recall rate. There are therefore strong
grounds for preferring double reading with arbitration to single
reading with CAD.
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Interval cancer developing within 3 years after recall to
assessment: a review of the South East Wales cases
JF Brook, J Evans, K Gower Thomas
Breast Test Wales, Cardiff, UK
Breast Cancer Res 2008, 10(Suppl 3):P21 (doi: 10.1186/bcr2019)
Objective To review interval cancers developing after initial recall
in the mammographic screening programme in South East Wales.
Methods Interval cancer data were collected from patient records
where the women had been recalled to assessment at the last
screening visit.
Results A total of 206 patients developed interval cancer following
a normal assessment result over a 3-year period; 169 patient
records were available for analysis. Fifty-six patients (33%) had
false negative results on screening mammogram. Seventy-one
cases (41%) were true interval cancers, nine (6%) were occult and
34 (20%) were unclassified. Of 56 false negative results, 53 were
assessed for the same area and three for a different area. Patients
were assessed for microcalcification (14 cases), asymmetric
density (22 cases), mass (six cases), spiculate density (two cases)
and distortion (nine cases). Six patients had either biopsy or cyst
aspiration. Almost 90% of the interval cancers were invasive
cancer. Thirty patients (55%) developed interval cancer between
12 and 24 months after screening.
Conclusion Assessment for glandular asymmetry and micro-
calcification should include biopsy in more cases.
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How does the location of a satellite screening site affect
uptake?
LS Wilkinson1, S Hudson2, J Peterson3
1South West London Breast Screening Service, St Georges
Healthcare NHS Trust, London, UK; 2Peel & Schriek Consulting
Limited, London, UK; 3Department of Geography, University
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Introduction Following the announcement of the Cancer Reform
Strategy and the anticipated introduction of digital mammography,
the South West London Breast Screening Service has investi-
gated the effect of accessibility and deprivation on uptake of
screening invitation in order to inform decisions on where to site
static and mobile screening facilities in future. There are currently
five static sites (hospital and commercial accommodation) and one
mobile van. It is known that the physical environment of the screen-
ing site may affect uptake, but the effects of poor accessibility and
local deprivation are not clear.
Methods  The local eligible population was analysed at Super
Output Area level, equivalent to approximately 20 postcodes or
200 eligible women. Information on local deprivation (Index of
Multiple Deprivation 2004), uptake (2004 to 2007), and travel time
by public transport was correlated for each Super Output Area.
Results There is a weak correlation between the Index of Multiple
Deprivation and uptake. The mean travel time to all screening sites
was 37 minutes but there is no correlation between travel time and
uptake. Uptake is lower in Super Output Areas closer to central
London. This may reflect high population mobility, which leads to
inaccurate information about the name and address of women
eligible for screening.
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Would male radiographers have an impact on breast
screening programme performance?
P Fitzpatrick1,2, A Winston1, T Mooney1
1National Cancer Screening Service, Dublin, Ireland; 2University
College Dublin, Ireland
Breast Cancer Res 2008, 10(Suppl 3):P23 (doi: 10.1186/bcr2021)
There is little research regarding attitudes to male radiographers
for mammography, particularly for screening. Radiographer recruit-
ment has been a challenge for BreastCheck, the Irish Breast
Screening Programme; to date, females are employed. Programme
expansion to the remaining half of the target population has com-
menced and doubling of radiographer numbers is required.
The aim was to document attitudes to male radiographers and the
effect on the programme performance parameters through a postal
questionnaire completed by 85.8% of a random sample of 2,000
women recently screened by BreastCheck.
Embarrassment was the commonest likely initial reaction if male
radiographers were present; greater among those at static units
(45.6%) than mobile units (38.4%) and in younger women (46%)
than older women (38.7%). Nine per cent would not have
proceeded if the radiographer was male; 17.5% (95% CI = 15.7%
to 19.4%) agreed that ‘If there were male radiographers I would
not return for another screening appointment’; and 18.3% were
unsure. One-quarter agreed ‘If I heard there could be male
radiographers it would change my opinion of BreastCheck for the
worse’. Response to gender was less marked when further investi-
gations to rule out or confirm cancer were in question.
This is the largest study of this issue; the correct balance between
equality and programme performance must be struck.
24
The first two years of digital mammographic screening in
New Zealand
J Walker, R Beedie, A Cave
BreastScreen Waitemata Northland, Auckland, New Zealand
Breast Cancer Res 2008, 10(Suppl 3):P24 (doi: 10.1186/bcr2022)
BreastScreen Waitemata Northland started as a new lead provider
for the New Zealand breast screening service in February 2006
with a new fully digital facility and several analogue regional
subsites. Some of these latter sites have subsequently been
replaced by two further digital facilities, gradually changing the
Available online http://breast-cancer-research.com/supplements/10/S3S8
proportion of digital screening mammograms from 32% to 73% of
our workload over 2 years, with 53,800 women screened. This was
the first digital screening site in New Zealand. We have compared
the results of screening with analogue and digital technology over
our first 2 years, in terms of recall rates, cancer detection rates and
positive predictive value, and found no overall significant difference
in any of these parameters. We have found improved detection of
malignant microcalcifications with digital mammography, with a
similar proportion of these malignancies that were either invasive
cancer or high-grade ductal carcinoma in situ as those detected
with analogue technology. However, we have found better
detection of nonspecific densities with analogue imaging. There is
a trend towards better cancer detection with analogue than digital
technology in the 64 to 69 years age group, which does not reach
statistical significance.
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Should prior film mammograms be digitised during the
transition to digital mammography?
S Taylor-Phillips1, MG Wallis2, AG Gale1
1Applied Vision Research Centre, Loughborough University,
Loughborough, UK; 2Cambridge Breast Unit, Addenbrooke’s
Hospital, Cambridge, UK
Breast Cancer Res 2008, 10(Suppl 3):P25 (doi: 10.1186/bcr2023)
National Health Service breast screening centres will soon make
the transition to digital mammography, and how that transition is
conducted may affect both performance and workflow. A trial of
digitising the prior film mammograms was conducted at University
Hospital (Coventry). Radiologists/advanced practitioners (n = 8)
read screening cases for 1.5 hours in two conditions: either prior
mammograms digitised (2905 digitiser at 75 μm; Array, USA) and
presented onscreen alongside the current mammograms; or
displayed in film format on a multiviewer. Measurements of eye
movements showed readers look at the prior mammograms a
greater number of times per case when digitised (t(7) = –2.73, P =
0.03). This could have implications for performance, as use of prior
mammograms is known to improve performance. After the study,
seven out of the eight readers expressed a preference for
digitisation of prior mammograms. Digitisation was trialled at two
different points in the workflow: before the screening session
resulted in 30% wastage due to women not attending; and after
the screening session caused a bottle-neck in workflow that slowed
the screening process by approximately half a day (3 minutes per
woman) in this implementation. The present study indicates that
digitising prior mammograms is beneficial for readers, but may delay
the production of results in the screening process.
26
The future of breast radiography: European perspective
H Rijken
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Breast Cancer Res 2008, 10(Suppl 3):P26 (doi: 10.1186/bcr2024)
Digital technology has entered the practice of mammography. In
the coming years, digital mammography will be gradually imple-
mented in most European countries and will change the practice of
mammography also from the radiographer’s perspective. A
computed radiography system is a quick simple conversion from
analogue to digital; there is little change in workflow, whereas the
introduction of full field digital mammography systems using direct
radiography detectors implies a significant change. The X-ray film
is replaced by solid-state detectors that convert X-rays into
electrical signals, producing images that can be studied instantly
on a computer screen. Thus, there are no cassettes, no markers,
no bucky to change, no darkroom, no waiting to check films, and
no viewboxes. Digital mammography provides higher resolution,
which may improve detection, but it also pronounces folds and
wrinkles, due to less optimal positioning.
Considering the professional status of the radiographer, we
encounter major differences in the various European countries. On
the one hand, in some countries, screening radiographers are
involved in film-reading and diagnostic procedures. On the other
hand, the radiographer might just be the one pressing the button.
Breast centres should employ well-trained specialized breast
radiographers, as full members of the multidisciplinary team. They
should be involved in the minimal invasive biopsy, ultrasound and
magnetic resonance imaging techniques, as well as in upcoming
new techniques, such as tomosynthesis, automated three-
dimensional breast ultrasound, dual-energy contrast enhanced
mammography, and so forth.
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The future of breast radiography: UK perspective
P Whelehan
National Breast Screening Training Centre, King’s College
Hospital, London, UK
Breast Cancer Res 2008, 10(Suppl 3):P27 (doi: 10.1186/bcr2025)
The current presentation reviews the radiography career structure
within the mammography speciality in the United Kingdom, focus-
ing particularly on the National Health Service Breast Screening
Programme (NHSBSP). Factors influencing role design will be
discussed, including national job profiles, the professional body
and NHSBSP guidance, service needs and cost-effectiveness.
Barriers to developing the workforce will be considered.
Results from the 2008 National Breast Screening Programme
workforce survey, currently underway, will be presented –
concentrating on the consultant radiographer role, and comparing
actual job specifications with those indicated in the relevant
guidance and with managers’ views on ideal job design.
It is postulated that while the radiography workforce has developed
enormously during recent years, further development is needed to
respond to current and future opportunities and challenges.
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Comparison of practitioner and assistant practitioner
mammograms
A-M Fretwell
Breast Cancer Res 2008, 10(Suppl 3):P28 (doi: 10.1186/bcr2026)
Abstract not submitted at time of publication.
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Assistant practitioner job satisfaction and retention
S Sellars
Breast Cancer Res 2008, 10(Suppl 3):P29 (doi: 10.1186/bcr2027)
Abstract not submitted at time of publication.
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Can we manage B3 lesions better?
S Pinder
Department of Academic Oncology & Division of Cancer Studies,
Guy’s Hospital, London, UK
Breast Cancer Res 2008, 10(Suppl 3):P30 (doi: 10.1186/bcr2028)
Within mammographic breast screening programmes in Europe, a
categorisation for nonoperative histology reporting is used from B1
normal and B2 benign through to B5 malignant. Definitive
diagnosis is possible for the majority of lesions on core biopsies,
but there remains a small proportion in the borderline category of
B3, uncertain malignant potential. These are lesions that are either
benign but known to be associated with malignancy, or which are
known to be heterogeneous and where sampling may have missed
a more worrisome area.
B3 lesions include entities such as radial scars, papillary lesions
and phyllodes tumours. Often more diagnostically difficult for the
pathologist are the atypical epithelial proliferations such as atypical
intraductal proliferations (akin to atypical ductal hyperplasia),
lobular neoplasia and columnar cell atypia/flat epithelial atypia.
Advances have been made regarding management of some of
these processes; it is established that the atypical intraductal
epithelial proliferations are more frequently definitively upgraded
with the use of wider gauge devices (for example, 11 G, 8 G) to
ductal carcinoma in situ. In such cases, diagnostic excision can be
avoided and therapeutic surgery undertaken. Conversely, it has
been shown that some papillary lesions may be excised by
mammotomy.
There are still few robust data, however, on outcome following a
B3 diagnosis of lobular neoplasia or of flat epithelial atypia. The
management of these lesions when identified in the core can
cause controversy and debate. Collaborative data collection of the
outcome of these uncommon entities is central to resolving the
question of optimal clinical management.
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Comparison of vacuum biopsy systems
R Wilson
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Breast Cancer Res 2008, 10(Suppl 3):P31 (doi: 10.1186/bcr2029)
More than 15 years ago breast radiologists recognised the limita-
tions of fine-needle aspiration and core biopsy as methods for
accurate percutaneous breast diagnosis and a variety of different
devices were developed to retrieve larger needle biopsy speci-
mens. Vacuum-assisted mammotomy (VAM) has been the most
successful of these methods. While core biopsy remains the
method of choice for routine needle breast biopsy, VAM is now in
routine use as a proven method for minimising the sampling error
of subtle and borderline breast lesions and for therapeutic excision
of benign breast lesions as an alternative to surgery. VAM achieves
significant 50% reduction in understaging of premalignant and
malignant disease.
VAM technology has been refined in recent years and there are
now four different VAM devices available. All are designed for use
under X-ray and ultrasound guidance. The third-generation devices
are closed systems that use larger gauge probes to ensure that
ample material can be rapidly acquired.
The latest devices are designed to be used with both prone table
and upright X-ray equipment, and are particularly suitable for lateral
approach stereotactic biopsy. Sensitivity rates for invasive and in
situ carcinoma of 95% to 100% are achievable and VAM should
now be considered routine for most stereotactic biopsy
procedures. VAM can also be used routinely in place of surgery for
the excision of benign lesions and for confirmation excision of
papillary lesions and radial scars.
Comparative analyses of the current VAM devices will be
presented.
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Follow-up results after vacuum excision
L Hamilton
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Breast Cancer Res 2008, 10(Suppl 3):P32 (doi: 10.1186/bcr2030)
Vacuum-assisted excision biopsy (VAEB) has two current indica-
tions: the removal of fibroadenomas at patient request, and the
removal of benign lesions of uncertain malignant potential (B3)
where the perceived risk of upgrade is low.
As the primary aim of VAEB of fibroadenomas is patient
satisfaction, we sent a postal patient satisfaction survey to all 81
women who had undergone VAEB of fibroadenomas in our unit.
After two postings we achieved a 59% response rate. The main
findings of the survey were that 79% of patients had complete
resolution of the palpable abnormality and that 96% would
recommend the procedure to others and undergo a further
procedure if required. Fifty-four per cent reported no pain during
the procedure and only 8% reported pain as greater than 2/10 on
a visual analogue scale. Postprocedure pain during the following
week, however, was rated at greater than 2/10 in 55%. The
commonest complication was bruising.
Our unit offers VAEB to patients with B3 lesions where no atypia is
present on core biopsy as an alternative to diagnostic surgical
excision. We decided to audit the first 43 such cases to assess the
upgrade rate and findings at follow-up imaging to see whether we
needed to refine our selection criteria for VAEB. Twenty-five
papillary lesions and 18 radial scars were excised under ultrasound
control, the majority with an 8 G device. Following VAEB there
were no upgrades of radial scars, but two lesions were missed due
to difficulty in excising subtle ultrasound abnormalities and required
wire localisation. Significant mammographic architectural distortion
often remained following VAEB of radial scars. An 8% upgrade of
papillary lesions was seen at final histology. A number of patients
went on to develop further papillary lesions in the same area at
follow-up. Some upgrades of papillary lesions might have been
avoided by careful multidisciplinary team discussion of the core
biopsies.
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Full field digital mammography: which equipment?
KC Young
National Coordinating Centre for the Physics of Mammography,
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Breast Cancer Res 2008, 10(Suppl 3):P33 (doi: 10.1186/bcr2031)
A wide variety of digital mammography systems are now commer-
cially available. These include digital radiography (DR) systems such
as the CSi/amorphous silicon detector (for example, GE Seno-
graphe 2000D, DS and Essential models), amorphous selenium (for
example, LoRad Selenia, Siemens Novation and Inspiration models,
IMS Giotto, Planmed Nuance) and a scanning system with silicon
detectors (for example, Sectra Micro Dose Mammography). A variety
of computerised radiography (CR) systems for mammography are
also available (for example, Fuji Profect, Kodak DirectView, Konica
Available online http://breast-cancer-research.com/supplements/10/S3S10
Regius 190, Agfa CR 85-X). Recently the CR manufacturers have
introduced new designs of phosphor plates. Such a wide variety of
systems raises the question of how the performances of these
systems compare with each other and with film-screen technology.
Another factor to be considered is the radiation dose required by
each system to reach an acceptable level of image quality.
To help answer these questions, the National Health Service
Breast Screening Programme and European Guidelines specify
minimum and achievable standards for dose and image quality. The
minimum standard is designed to ensure that new digital systems
are at least as good as the previous film-screen systems. This
lecture compares the measurements on a wide range of digital
systems against the standards in the European Guidelines. The
overall conclusion is that the DR systems can generally meet the
achievable image quality standards for a dose lower than that used
for film-screen systems. While the new designs of CR plate have
brought about measurable improvements, most CR systems still
require doses higher than film-screen systems to meet the
minimum standards for image quality.
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Developments in digital mammography equipment have been very
fast: the first digital mammography system was introduced in 1999,
and new systems using different physical principles have since
emerged and major improvements in equipment have occurred.
These improvements have solved some important quality issues
that were present in some early digital mammography systems.
However, image quality problems still occur relatively frequent and
technical quality control is important to recognize and quantify
them. Both the acceptance/6-monthly quality control tests and (at
least) weekly quality control as recommended in the European
Guidelines are therefore essential for high-quality mammography.
In the Dutch screening programme, technical quality control is
performed against the Dutch Guidelines, which are very similar to
the European Guidelines for Quality Assurance in Breast Cancer
Screening and Diagnosis. However, some additional tests are
performed: a more extensive noise evaluation and a more precise
image quality evaluation. These might be included in an update of
the European Guidelines.
In this presentation, some major failures, which have occurred
recently, will be shown: significant additional noise (electronic and
structural noise), disturbing artefacts, insufficient image quality,
major ghosting, and so on.
Recently the European Reference Organisation for Quality
Assured Breast Screening and Diagnostic Services (Euref) started
a new project to update the European Guidelines, and is
performing type testing in which it is determined whether a system
is able to pass the Guidelines. When buying new mammography
equipment, this type testing (by Euref) might be taken into account.
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Breast tomosynthesis in practice
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One of the factors limiting the sensitivity of conventional mammo-
graphy (analogue and digital) is the obscuring effect of dense
breast tissue overlying and underlying a tumor. This problem
should be reduced by a tomographic technique. Tomosynthesis
implies acquiring multiple projection images over a certain angular
range with mathematical reconstruction of slices parallel to the
detector plane. This technique is made possible by the recent
development of digital detectors with high efficiency, which are
capable of acquiring low-dose images with fast read-out and
minimal image lag.
Within our group, optimization studies of tomosynthesis have been
performed regarding factors such as angular range, number of
projection images, data collection mode, and so on.
Tomosynthesis has also been under clinical evaluation in our
institution for about 2 years. We have analyzed a series of breast
cancer patients selected on the basis of difficult two-dimensional
mammograms, and graded the visibility of the malignancies on two-
dimensional as well as on three-dimensional mammograms.
Furthermore, we have classified the mammograms according to
the BIRADS Breast Imaging Reporting and Data System.
The results have shown a significantly better visibility and more
accurate BIRADS classification with tomosynthesis. Accordingly,
the results suggest that tomosynthesis is a more sensitive
technique for the detection of breast cancer than conventional
digital mammography. Further studies of the sensitivity and
specificity are underway.
We believe that tomosynthesis will play an important role in the
detection and diagnosis of breast cancer in the future.
POSTER PRESENTATIONS
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Accuracy of preoperative size prediction in infiltrating
lobular carcinoma: comparison of mammography,
ultrasound and clinical examination
F Canavan, B Atlas, A Sever, P Mills
Peggy Wood Breast Care Unit, Maidstone NHS Trust, Maidstone,
UK
Breast Cancer Res 2008, 10(Suppl 3):P36 (doi: 10.1186/bcr2034)
Objective Accurate preoperative size measurement of infiltrating
lobular breast carcinoma (ILC) is of utmost importance in staging
and prognosis. ILC is notoriously difficult to measure by
conventional techniques, and surgical excision is often repeated for
positive margins.
Method One hundred patients with biopsy-proven ILC underwent
mammography, ultrasound (US) and clinical examination prior to
surgery between 2000 and 2005. Correlation between histological
and estimated size was determined. Insufficient funding prevented
inclusion of magnetic resonance imaging (MRI) as a standard
modality.
Results Over 50% had palpable lesions on examination (n = 53).
The most frequent mammographic finding was a mass lesion (n =
45) without microcalcification (n = 40). Pearson correlation
coefficients for each modality (mammogaphy, clinical, US) were
similar (r = 0.77, r = 0.76, r = 0.61; P < 0001). Paired t tests
demonstrated mean size differences of +1.31 mm (clinical, n =
53), –3.18 mm (mammography, n = 70) and –4.23 mm (US, n =
89).
Conclusion  Correlations between estimated and actual tumour
size for each modality (mammography > clinical > US) were
similar. US and mammography underestimate size; clinical
examinations overestimate it. Overall, conventional imaging is not
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an accurate size predictor of ILC. Studies have shown superiority
of MRI in size estimation of ILC. We recommend standard
inclusion of preoperative MRI for ILC on this basis.
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Background and objective Stereotactic and ultrasound-guided
vacuum-assisted biopsy (VAB) has an important role in
assessment of screen-detected lesions, particularly suspicious
microcalcification. VAB technology has rapidly developed and
three systems are now being evaluated at our institution; Suros
(Suros Surgical Systems, Indianapolis, IN, USA), EnCore
(SENORX, Columbia, USA) and Mammotome (Ethicon Endo-
Surgery Inc., Cincinnati, OH, USA). Technical variations between
these systems may impact on procedure effectiveness and patient
experience. Our aim was to assess and compare these differences.
Methods A prospective study of 60 women undergoing image-
guided VAB over 4 months was performed. Four experienced
radiologists used each VAB system equally. Subjective operator
experience and any technical or patient complication were
recorded. A patient pain questionnaire with follow-up of
haematoma formation was performed.
Results Subjective and objective parameters for the three VAB
systems were tabulated, highlighting strength and weaknesses.
The length of procedure varied according to the number of cores,
clip placement and the particular system used. Postprocedural
pain and haematoma formation also showed variation.
Conclusion  The choice of VAB equipment is dependent on
operator and patient experience but should not compromise
diagnostic yield. Technical features of some VAB systems may
improve effectiveness for particular lesions; awareness of these
variations allows safer use.
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Columnar cell lesions with atypia: radiological features and
surgical outcome
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Background and objective Columnar cell change with atypia
(CCCA) is increasingly diagnosed on core biopsy for indeterminate
microcalcification, and may be associated with noninvasive ductal
carcinoma in situ (DCIS) or invasive cancer. Few data exist on the
risk of cancer in isolated CCCA lesions. We aimed to determine
the rate of surgical upgrade to malignancy in CCCA and the
predictive imaging features.
Methods A 5-year retrospective search of our database revealed
CCCA as the primary finding in 21 cases of core biopsy. We
reviewed mammographic features and surgical histology for each
case.
Results  All cases were screen-detected via indeterminate
microcalcification on the mammogram; none had a palpable mass.
Three patients declined surgery; 14 patients underwent diagnostic
surgical excision and four patients had vacuum excision. Overall,
33% (n = 6) were upgraded to cancer; comprising low-grade
DCIS (n = 2), invasive ductal carcinoma (n = 2), G1 tubular (n = 1)
and G1 apocrine (n = 1). Of those surgically excised (n = 14),
43% were upgraded to cancer. Sixty-six per cent of cases (n = 12)
revealed CCCA alone or with other benign changes. A micro-
calcification cluster size >10 mm appeared predictive for upgrade.
Conclusion  CCCA presents as nonpalpable, clustered
indeterminate microcalcifications on mammography. From this
series, we recommend surgical excision for all cases where atypia
is found with columnar cell change.
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Breast biopsy pathology request forms: are the
radiologists completing them correctly and legibly?
L Neville1, N Ridley2, S Taylor2, J Armstrong1, J Cook2
1Pathology Department, Great Western Hospital, Swindon, UK;
2Breast Screening Unit, Great Western Hospital, Swindon, UK
Breast Cancer Res 2008, 10(Suppl 3):P39 (doi: 10.1186/bcr2037)
Introduction Radiologists rightly feel that imaging request forms
should be completed correctly. Pathologists also require a mini-
mum dataset to be completed on all histopathology requests. The
breast screening radiologists and pathologists initiated an audit of
wide-bore needle breast biopsy pathology request forms.
Standard One hundred per cent of pathology forms should be
completed correctly and legibly.
Methods Forty breast wide-bore core biopsy pathology forms
were reviewed. The principle data collected included patient
demographics, clinical details and requesting doctor information.
Forms were scored for legibility. Each item of data from each form
was collected and compared against the standard.
Results The initial audit showed multiple minor deficiencies in form
completion. Only 67.39% of total request details were completed
correctly and 82% of request forms were easily legible. The
radiologists did not appreciate the significance of a number of the
pathology fields. These results were reviewed with the
pathologists. Cross-checking by imaging assistants was
introduced. A re-audit was performed, showing improvement;
84.9% of total request details were now completed correctly and
all forms were legible.
Conclusion Correct completion of pathology forms is essential.
Breast radiologists may not always appreciate all of the data
required by their local pathologists.
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Breast screening assessment clinics: as easy as ABC
S Taylor, N Ridley, S Brown, N Gillhespy
Breast Screening Unit, Great Western Hospital, Swindon, UK
Breast Cancer Res 2008, 10(Suppl 3):P40 (doi: 10.1186/bcr2038)
Introduction We have introduced a simple ABC classification
system to streamline the patient pathway during the assessment
clinic. Abnormalities are graded as A, B or C at consensus by the
radiologists and reporting radiographers depending upon the
mammographic likelihood of cancer and biopsy. This means that
patients can be allocated to one of our three assessment clinics
and at specific times within those clinics to facilitate workflow. This
system has been in place for several years. Clinics have an average
of eight patients and finish on time with minimal patient delay. We
were interested to see how accurately our grading system corre-
lated with final diagnosis, number of biopsies and additional films.
Methods We audited 30 assessments.
Available online http://breast-cancer-research.com/supplements/10/S3S12
Results Films per patient: A, 0.7; B, 1.9; C, 2.2. Biopsy rate per
patient: A, 0; B, 0.27; C, 0.7. Cancer diagnosis per patient: A, 0;
B, 0.18; C, 0.44.
Conclusion The results confirm that our grading system correlates
with final diagnosis, the number of films and the biopsy rate. The
planned extension of the breast screening programme will further
increase workload in the assessment clinics. A simple ABC
grading method can be introduced easily within the screening
programme to improve assessment clinic efficiency.
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Can computed tomography replace nuclear medicine
scans in the staging of breast cancer?
N Ridley, S Taylor, R Young
Breast Screening Unit, Great Western Hospital, Swindon, UK
Breast Cancer Res 2008, 10(Suppl 3):P41 (doi: 10.1186/bcr2039)
Introduction Selected patients with breast cancer are staged
using computed tomography (CT). CT demonstrates disease in the
lungs, liver, lymph nodes and bones. Traditionally, isotope bone
scanning (NM) is used to stage the skeleton. If bony pathology is
imaged as well on CT as on NM, it may be possible to dispense
with the bone scan.
Methods Breast cancer patients who had CT and bone scanning
within 1 month of each other were reviewed retrospectively to
correlate the pathology.
Results Out of 44 combined scans, 12 were normal on both
investigations. Seventeen CT scans had normal bones but demon-
strated extraskeletal pathology. On seven CT scans, the bony
metastases were better visualised than on NM. Five bone scans
showed abnormalities outside the CT scan field (humerii and
femora) but only one of these was a solitary abnormality. Five
hotspots on NM were confirmed as a degenerative change on CT.
Conclusion CT is as sensitive as NM and is more specific, with the
exception of those areas not included on the scan; however, these
areas could be included on the CT scan. CT will show additional
pathology. Bone scanning may not be needed when patients have
had a CT scan.
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Audit of a radiographer/nurse-led family history breast
cancer clinic
SA Willson, R Edwards, J Reeves, PA Middleton, AM Klidjian
Breast Care Centre, Taunton and Somerset NHS Foundation Trust,
Taunton, UK
Breast Cancer Res 2008, 10(Suppl 3):P42 (doi: 10.1186/bcr2040)
Following the publication of National Institute of Clinical Excellence
(NICE) guidelines for familial breast cancer [1], we implemented
nurse-led and radiographer-led family history clinics. These
replaced a formerly ad hoc system of general practitioner mammo-
gram requests and referrals to the surgical breast clinic.
At the clinic, women were assessed as to their level of increased risk
of breast cancer by a detailed family history. They were taught breast
self-examination and were put onto appropriate mammography
surveillance when indicated or were reassured and discharged.
The majority of referrals were from general practitioners – 62% of
women were found to be in the high (23%) and moderate (39%)
risk categories. Thirty-eight per cent of patients were found to be at
population risk (24%) or were inappropriate referrals.
In conclusion: (1) nurse/radiographer-led family history clinics are
effective and an efficient use of resources; (2) there is a high
degree of client satisfaction; and (3) there are a significant number
of referrals that were not indicated according to NICE guidelines,
and action is required to address this issue.
Reference
1. NICE Guideline CG41: The Classification and Care of
Women at Risk of Familial Breast Cancer in Primary, Sec-
ondary and Tertiary Care. NHS National Institute for Health
and Clinical Excellence; 2006.
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Breast cancer in young identical twins
SA Willson, PA Middleton
Breast Care Centre, Taunton and Somerset NHS Foundation Trust,
Taunton, UK
Breast Cancer Res 2008, 10(Suppl 3):P43 (doi: 10.1186/bcr2041)
A 25 year old presented with a 12-week history of a mobile breast
lump. Mammography and breast ultrasound demonstrated a 3 cm
mass lesion, extensive microcalcification and axillary lymphadeno-
pathy. Core biopsies confirmed a grade 3 ductal carcinoma and
high-grade ductal carcinoma in situ.
Several weeks later her identical twin sister attended the family
history breast cancer clinic. Clinical breast examination was normal
but, despite the patient’s age, it was decided to carry out a
baseline mammogram. This showed widespread casting micro-
calcification, and core biopsies confirmed extensive high-grade
ductal carcinoma in situ.
When one twin has breast cancer, one-third of identical twins
develop breast cancer at some time in their lives. Nonidentical
twins of breast cancer patients have a much smaller risk of the
disease. This suggests identical twins gain their increased risk by
inheriting the same set of genes as their sister with cancer, rather
than through sharing the womb or being brought up together.
Where one twin develops breast cancer at an early age, the other
has a high chance of doing likewise.
Reference
1. Peto J, Mack TM: High constant incidence in twins and
other relatives of women with breast cancer. Nat Genet
2000, 26:411-414.
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A practical perspective of computerised radiography on a
mobile screening van
A Turnbull, B Young, K Hayer, J Bacon, J York, S Farmer
Derby Breast Unit, Derby City Hospital, Derby, UK
Breast Cancer Res 2008, 10(Suppl 3):P44 (doi: 10.1186/bcr2042)
Prohibitive costs of implementing direct digital mammography
throughout our unit, as we would need to replace analogue
machines on two mobile screening vans and at one satellite static
unit, directed us towards the interim solution of computerised
radiography (CR).
An agreement was made between ourselves and Fuji to pilot the
use of CR on a mobile screening van.
We looked at the practicalities of installation of equipment, training
and changes to working practices for radiographers, film-reader
comparison of images and technical recall rates.
The pilot has been in place for 1 year; 720 independent
observations have been made by one consultant radiologist and
three mammographic film-readers, comparing hardcopy CR
images with previous analogue films, using the criteria set out in
the National Health Service Breast Screening Programme
evaluation of digital equipment document.
Breast Cancer Research    July 2008 Vol 10 Suppl 3 Symposium Mammographicum 2008S13
The results demonstrate that CR printed films are at least as good
as analogue films, and in many cases better. The spread of relative
diagnostic value was between –1 (0.4%) and +2 (14.4%) in favour
of CR. This was most marked in the dense breast patterns, as
shown in previous publications.
Aspects of physics testing will also be discussed.
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Comparison between the NVQ Level 3 in Diagnostic and
Therapeutic Care and the BTec Professional Development
Certificate for assistant practitioners in imaging: the Derby
experience
M Cross, R Riley, T Bluck, D Samra
Derby Breast Unit, Derby City Hospital, Derby, UK
Breast Cancer Res 2008, 10(Suppl 3):P45 (doi: 10.1186/bcr2043)
The poster looks at two different learning pathways for training
assistant practitioners in mammography. Four assistant
practitioners were trained: two practitioners using the NVQ Level 3
in Diagnostic and Therapeutic Care, delivered and supported by
the local Hospital Trust; and two practitioners doing the BTec
Professional Development Certificate at Derby University.
Comparisons are made between both courses with regard to
timescales and academic content, and how these can be linked to
further professional development. Advantages and disadvantages
of both courses are discussed.
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The seated mammographer: a radical improvement in
ergonomics
JR Lavell, J Burkitt
University Hospital Birmingham, West Midlands, UK
Breast Cancer Res 2008, 10(Suppl 3):P46 (doi: 10.1186/bcr2044)
Anecdotally there are many mammographers that experience
musculoskeletal discomfort, although it does not feature highly in
the published literature. The aim of the present project was to
reduce musculoskeletal discomfort and pain associated with
mammography, through examining ways of improving posture and
thereby reducing muscular loading.
The poster demonstrates how we evaluated our working practice
with the support of ergonomic professionals, in order to reduce
high-risk techniques and postures. Our evaluation led to a radical
change in the way our mammographers undertake the examination.
The present project has demonstrated the importance of examining
our own working practice, seeking informed professional advice
and being willing to change or adapt our techniques to minimize
long-term health implications.
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Only skin deep: a pictorial review of skin and
subcutaneous lesions
P Moyle, M Hunt, P Britton
Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge, UK
Breast Cancer Res 2008, 10(Suppl 3):P47 (doi: 10.1186/bcr2045)
Many skin and subcutaneous lesions can be demonstrated on
screening mammograms, and may mimic malignancy. Careful
clinical history and meticulous annotation is paramount to avoid
pitfalls in mammographic interpretation, inappropriate recall and
further evaluation. The National Health Service Breast Screening
Programme [1] states that radiographers should note on the
screening sheet any significant or relevant symptoms reported by
the women or observed during the examination.
We shall illustrate 20 examples of radiographer-annotated lesions
and correlate them with their corresponding mammograms and
ultrasounds. Examples include sebaceous glands, seborrhoeic
keratosis, skin tags, dimples from underlying malignancy, surgical
scars, artefacts mimicking microcalcification, distended veins of
Mondor’s disease, central venous thrombosis, iliac vein thrombosis
as well as peau d’orange.
Correct annotation can help to avoid misdiagnosis, unnecessary
recall, anxiety and further investigations. The importance of
meticulous radiographer annotation is emphasized.
Reference
1. NHSBSP National Quality Assurance Coordinating Group for
Radiography: Information and Advice for Health Care Pro-
fessionals in Breast Screening. NHSBSP Publication No.
53, section 8.1. December 2002.
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Interval cancer data collection within the South West
Quality Assurance Reference Centre
E Kutt1,2, F Johnson1, D Harker1
1South West Region Breast Screening Quality Assurance
Reference Centre, Bristol, UK; 2Avon Breast Screening Unit,
Bristol, UK
Breast Cancer Res 2008, 10(Suppl 3):P48 (doi: 10.1186/bcr2046)
Interval cancers are an important measure of screening quality and,
although they are an expected and inevitable part of any cancer
screening process, their numbers should be kept as low as possible.
Interval breast cancer cases may be identified from a number of
sources, including symptomatic clinics, pathology laboratories and
cancer registries.
The South West Quality Assurance Reference Centre (QARC) has
developed a database to assist in the collection and validation of
interval cancer data. The database has been developed collabora-
tively with the South West Cancer Registry, which sits within the
South West Public Health Organisation (SWPHO). Service-level
agreements are in place between the QARC and the nine Trusts
hosting the Breast Screening Units and with the SWPHO.
The present poster details the information flows between the
breast screening units in the South West, QARC and the SWPHO
by comparing and contrasting viable data items. The system not
only identifies potential interval cancers but will also aid validation
and verification of cancer data held by the SWPHO. Validated data
will be fed back to the screening units.
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Metastases to the breast
J Arora1, C Betancourt2, D Dalgliesh2, D Goddard2
1Bristol Royal Infirmary, Bristol, UK; 2Royal United Hospital, Bath, UK
Breast Cancer Res 2008, 10(Suppl 3):P50 (doi: 10.1186/bcr2048)
Introduction Metastases to the breast (MB) account for 0.5% to
6.6% of breast malignancies. Diagnosis is difficult because of
nonspecific clinical, radiological and histological manifestations. To
plan appropriate management, it is important to differentiate MB
from primary breast malignancy (PBM).
Available online http://breast-cancer-research.com/supplements/10/S3S14
Objective To review the clinical and imaging presentation of MB
and to differentiate these from PBM.
Method We retrospectively identified over a 15-month period six
pathologically proven cases of MB from an extramammary malig-
nancy. The clinical, ultrasound and mammographic presentations
are tabulated. These are compared with the features of PBM.
Results  Primary tumours included one melanoma, two lung
cancers, one lymphoma, one gynaecological malignancy and one
unknown primary. The MB was the presenting feature in four out of
six cases. Five patients had both mammogram and ultrasound
examinations, and one of these had breast MRI in addition; one
patient had ultrasound only. Imaging features were similar to those
discussed in the literature and include well-defined nodules,
associated axillary lymphadenopathy and an absence of distortion
or microcalcifications.
Conclusion  Although radiological appearances may be helpful,
MB must be differentiated from PBM by appropriate histo-
pathologic examination, in order to preclude unnecessary mastec-
tomy and to guide further management.
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Predicting the presence of invasive carcinoma from the
extent of mammographic malignant microcalcification and
grade of ductal carcinoma in situ on core biopsy: results
from a National Health Service Screening Programme
EAM O'Flynn1, JC Morel1, J Gonzalez2, H Purushothaman1, 
D Evans1, R Wasan1, MJ Michell1
1South East London Breast Screening Programme and National
Breast Screening Training Centre, King’s College Hospital NHS
Foundation Trust, London, UK; 2Department of Clinical Research
Statistics, King’s College Hospital NHS Foundation Trust, London,
UK
Breast Cancer Res 2008, 10(Suppl 3):P51 (doi: 10.1186/bcr2049)
Four hundred and two cases of malignant microcalcification pre-
senting through a National Health Service screening programme
over a 10-year period were analysed. The final histological diag-
nosis was ductal carcinoma in situ (DCIS) only in 71% (284/402
cases) and DCIS with a focus of invasive disease in 29%
(118/402 cases).
There were significant associations with the presence of invasive
disease for the histological grade of DCIS (χ2 = 9.06, P = 0.003)
and for the cluster size (χ2 = 12.18, P = 0.0001). The proportion
of cases with invasive tumour increased with increasing DCIS
grade, from 13% (4/31) for low-grade DCIS to 36% (86/239) for
high-grade DCIS; increasing cluster size, from 20% (27/136)
<11 mm to 45% (18/40) >60 mm; and with increasing DCIS
grade within each microcalcification cluster size category: <11 mm
from 13% to 25%, 11 mm to 30 mm from 13% to 36%, 31 mm to
60 mm from 0% to 41%, and >60 mm from 25% to 55% for low-
grade to high-grade DCIS, respectively.
The Hosmer–Lemeshow goodness-of-fit test supports this model
(χ2 = 0.59, P = 0.96). The multidisciplinary team can use these
data to estimate the risk of invasive cancer and to formulate
appropriate management to minimise the number of patients
requiring more than one operation, currently 49% for those with
DCIS on core biopsy in a screening population [1].
Reference
1. UK NHS Breast Screening Programme Statistics 2005-2006
[http://www.cancerscreening.nhs.uk/breastscreen/statistics.html]
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HILINA: minimising the breast compression time at
stereoguided biopsy
GP Naisby1, H Harris1, K Robson2
1James Cook University Hospital, Middlesbrough, UK; 2Regional
Medical Physics Department, Newcastle General Hospital,
Newcastle upon Tyne, UK
Breast Cancer Res 2008, 10(Suppl 3):P52 (doi: 10.1186/bcr2050)
With mammography alone it is often difficult to distinguish
between benign and malignant microcalcifications in the breast,
and image-guided biopsy is widely undertaken for clarification.
National Health Service Breast Screening Guidelines recommend
that representative microcalcifications must be demonstrated in
core specimens on specimen radiography: to achieve high
absolute sensitivity for malignancy, at least five flecks of calcium in
three cores are required [1].
An innovative device (HILINA), which was designed and developed
locally, fits onto the tube housing of the Novation/Nova with Opdima
digital stereo biopsy unit (Seimens Corporation, Camberley, UK),
and allows direct digital capture of core biopsy images during
breast compression. This shortens the breast compression time and
allows rapid termination of the biopsy procedure.
Analysis of the visibility of microcalcifications in core biopsy
specimens from 20 consecutive patients has demonstrated that
this is a satisfactory, cost-effective method of documenting
adequate sampling when compared with cabinet computed
radiography.
Reference
1. Wilson R, Liston J: Clinical Guidelines for Breast Cancer
Screening Assessment, NHS Breast Screening Programme.
NHSBSP Publication No 49. 2nd edition. Sheffield: NHS
Cancer Screening Programmes; January 2005:11-16. [http://
www.cancerscreening.nhs.uk/breastscreen/publications/
nhsbsp49se.pdf]
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Consensus approach to discrepancies arising from
independent double reading of screening mammograms
R Hiscock, G Hurst
Norfolk and Norwich University Hospital, Norwich, UK
Breast Cancer Res 2008, 10(Suppl 3):P53 (doi: 10.1186/bcr2051)
Objective  To establish whether the consensus approach is a
reliable method for review of discordant results of double-reported
mammograms undertaken through the National Breast Screening
Programme at the Norfolk and Norwich University Hospital.
Method Analysis of a comprehensive database already held of all
cancers detected between screening rounds enabled identification
of all cancer cases that went through the consensus process and
were considered normal. These cases were reviewed to ascertain
whether the radiological appearance considered at consensus was
actually the site of the subsequently diagnosed cancer.
Results  Over the 6 years of the study three false negative
outcomes were identified from 2,264 cases returned to the normal
screening round from the consensus process. Out of 1,942 cases
that proceeded to assessment through the consensus process,
however, 161 cancers were detected, of which 112 had an
invasive component. Eighty-three of these cancers were 15 mm or
less in size. This left 49 noninvasive (ductal carcinoma in situ)
cases, of which 31 were high-grade ductal carcinoma in situ.
Conclusion These findings illustrate the success of the consensus
approach to discordance in screen reading. A combination of two-
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view mammography and independent double reading has seen an
increase in cancer detection.
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Evidence to support the use of ultrasound in addition to
mammography as part of breast cancer follow-up
surveillance
SN Andrews, DJ Ferguson, JM Dunn, RR Davies, MJ Cooper
Department of Breast Surgery, Royal Devon & Exeter Hospital,
Exeter, UK
Breast Cancer Res 2008, 10(Suppl 3):P54 (doi: 10.1186/bcr2052)
Introduction  Following breast cancer treatment, our unit has
routinely offered ultrasound in conjunction with mammography as
part of radiological follow-up surveillance. The primary objective
was to assess the value of ultrasound as an adjunct to mammo-
graphy in surveillance detection of local/nodal recurrent disease.
Methods A retrospective analysis of all breast cancer patients with
recurrence who had completed 5 years of follow-up was
performed. The site of recurrence was noted (local and/or nodal)
and the method of detection was also recorded. The recurrences
primarily detected as a result of radiological surveillance invite
were investigated and noted to be apparent by mammogram
exclusively, apparent by ultrasound exclusively or apparent by both
modalities.
Results  During the 8-year study period, 2,580 patients were
treated surgically and completed follow-up; 116 recurrences were
detected (4.5%). From the 116 patients the total number of
recurrences detected purely as a result of radiological surveillance
invite was 43% (n = 50). Of those, 22% (n = 11) were ultrasound
detectable only. The primary method of detection was very different
depending on the site of recurrence.
Conclusion  Ultrasound does have value in radiological breast
cancer follow-up as an adjunct to mammography, being the primary
and exclusive detection tool in 1/5 of radiologically detected cases
overall. Ultrasound surveillance has primarily detected 25% of
nodal recurrence that otherwise would have lead to delayed
diagnosis.
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The developing role of mammographers in performing
sentinel node injections in a specialist breast care centre
A Kelly, AM Kelly, J Kopman
Nightingale Centre and Genesis Prevention Centre, Manchester, UK
Breast Cancer Res 2008, 10(Suppl 3):P56 (doi: 10.1186/bcr2054)
The purpose of the present poster is to highlight the efficiency and
cost-effectiveness of a mammographer-led sentinel node injection
session within a specialist breast care centre. The axillary lymph
node status provides the most important staging information and
offers improved regional control. Sentinel lymph node biopsy has
been reported as providing a safe and sensitive method of
predicting axillary metastases and can help prevent unnecessary
axillary surgery in a number of breast cancer patients [1]. Sentinel
node injections have developed into a significant aspect of the
mammographer’s role expansion and have become fundamental in
a specialised breast care centre. Utilisation of mammographer’s
skills in an extended role has increased motivation and job
satisfaction and has provided career enhancement. Mammo-
grapher-led sentinel node injection sessions have reduced the
inpatient stay, improved the patient’s journey and reduced the dose
of radioisotope given to the patient.
Reference
1. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW,
Krasne DL: Improved axillary staging of breast cancer with
sentinel lymphadenopathy. Ann Surg 1995, 222:394-401.
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Large-volume Mammotome biopsy may reduce the need
for surgery in screen-detected papillary lesions
PJ Carder1, P Burrows2, ST Dennis2, N Sharma2
1Bradford Teaching Hospitals NHS Foundation Trust, Bradford,
UK; 2Pennine Breast Screening Service, St Lukes Hospital,
Bradford, UK
Breast Cancer Res 2008, 10(Suppl 3):P57 (doi: 10.1186/bcr2055)
The majority of papillary breast lesions diagnosed on conventional
needle-core biopsy are classified B3 – of uncertain malignant
potential. There is currently debate whether such lesions require
surgical excision, particularly if there is no epithelial atypia. The risk
of associated malignancy is low.
Large-volume Mammotome (Ethicon Endo-Surgery, Cincinnati,
OH, USA) biopsy can sample lesions more extensively, obviating
the need for surgery in some cases. We review the impact of
adopting this approach for the management of screen-detected B3
papillary lesions without atypia.
Fifteen patients presenting through the Pennine Breast Screening
Programme between 19 December 2005 and 23 August 2007 had
core biopsies containing a B3 papillary lesion without atypia. Mammo-
graphically, 12 patients had calcification and three presented masses.
Three patients underwent surgical excision, 10 underwent Mammo-
tome biopsy and two patients had no subsequent procedure.
All three patients undergoing surgery showed benign intraductal
papillomata. Of the 10 patients undergoing Mammotome, eight
were confirmed as benign. None subsequently developed malig-
nancy. One Mammotome patient contained ductal carcinoma in
situ (DCIS); another, an atypical epithelial proliferation resulting in
surgery and a subsequent diagnosis of DCIS. Both cases were
distinctive in presenting with segmental calcification, and in both
DCIS had arisen in the context of multiple papillomata.
Large-volume Mammotome biopsy may reduce the need for
surgery in selected screen-detected papillary lesions.
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Significance of new benign densities seen on screening
mammograms of women older than 60 years of age
C Bradley, A Rahman, A Hubbard
Castle Hill Hospital, Cottingham, UK
Breast Cancer Res 2008, 10(Suppl 3):P58 (doi: 10.1186/bcr2056)
Breast cancer risk is strongly related to age, with 80% of cases
occurring in women over 50 years old. Small, benign-looking
lesions in perimenopausal women have a very low risk of malig-
nancy and are not recalled. We undertook an audit to assess the
significance of a single, new, apparently benign (R2) lesion seen
on both views on screening mammograms of women aged 60
years and above. Any new density with suspicious imaging was
recalled without being entered into the audit.
A total of 70 women were included. Fifty-seven patients had no
significant findings or cysts on ultrasound, with a normal
Available online http://breast-cancer-research.com/supplements/10/S3S16
postaspiration mammogram. Three patients had cyst aspirate sent
for cytology, and one of these went on to have a core biopsy for a
C3 result. Ten patients had a solid lesion on ultrasound warranting
a core biopsy, two of which had a B5 lesion.
Although the majority of patients had a benign result, a total of
three out of 70 patients had an abnormal cytology/histology. We
recommend that new benign densities seen on two views in
women aged over 60 years old are fully assessed and biopsied to
determine their nature.
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Digital breast screening: does it do what it says on the tin?
A Teape, A Connors, P Mclarnon
BreastCheck Southern Unit, Cork, Ireland
Breast Cancer Res 2008, 10(Suppl 3):P60 (doi: 10.1186/bcr2058)
Introduction Screening women in the Southern Region of Ireland
commenced in December 2007. Prior to this, screening was only
available in the eastern regions and the two units in this region had
a mix of analogue and digital equipment.
Background Although the BreastCheck Southern Unit is working
with digital systems, our clinicians have come from an analogue
background. Practice shows that, despite manufacturers’ claims on
the reduced need for certain imaging at assessment, this is not
happening in reality. Historically, women recalled to assessment
had a number of further views, ultrasound and, in some instances,
a biopsy performed. The average time spent in the clinic for each
woman was 2 hours. As this unit is digital and has only
commenced its service, an audit was commissioned.
Methods The audit will include data for a 4-month period from
January 2008, involving all women recalled to assessment. The
following will be evaluated: compression used at initial screen and
whether low levels of compression increase the recall rate; further
imaging and whether these images add any new information to aid
diagnosis, especially with the advances in digital imaging; and
streamlining the clinics to provide a more efficient service for our
clients.
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Derby results and practical experience of breast imaging in
women following supradiaphragmatic irradiation for
Hodgkin’s disease
AE Turnbull1, M Bagnall1, S Puri1, M Persic2
1Breast Unit, Derby City Hospital, Derby, UK; 2Department of
Oncology, Derby Royal Infirmary, Derby, UK
Breast Cancer Res 2008, 10(Suppl 3):P61 (doi: 10.1186/bcr2059)
The national recall programme for women who had supradiaphrag-
matic irradiation for Hodgkin’s disease under the age of 30 years
began in late 2003. In Derby, from an initial identified group of 56
women, 36 attended for a 1-hour consultation with a consultant
oncologist. From these 36 women, 33 have attended for
surveillance.
In the group offered imaging surveillance, all 33 women took up
the invitation. When magnetic resonance imaging (MRI) is
indicated, it is done first; then the woman attends for
mammography, MRI results and any focused ultrasound needed
the following day.
See Table 1 for results. Five of the six MRI recalls were from a first
screen, and the other from a second screen. One ductal carcinoma
in situ was diagnosed in a lady with breast implants.
From the 56 eligible women, there were four with breast cancer:
one woman diagnosed as above, two women from the National
Health Service Breast Screening Programme and one woman
symptomatically in 2007. The radiology and pathology of these
cases will be presented.
We commence family history screening with MRI soon and plan to
apply this method, which works very well and within tight time
limits.
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Maximising round length in a large National Health Service
breast screening unit
BA Eckersley, S Berry, R Robertson
Nightingale Centre and Genesis Prevention Centre, Manchester, UK
Breast Cancer Res 2008, 10(Suppl 3):P62 (doi: 10.1186/bcr2060)
Within the National Standards for Breast Screening is the objec-
tive to ensure that women are recalled for screening at appropriate
intervals.
The Manchester Breast Screening Unit has utilised the ability to
specify batches from the health authorities in a specific order, to
maximise the call and recall system for women eligible for primary
screening.
The minimum standard for the criterion of the percentage of eligible
women whose first offered appointment is within 36 months of their
previous screen is ≥90%. Using the computer program has
maximised the appointment scheduling, but in addition has derived
benefits to the Commissioning Primary Care Trusts. The appoint-
ment timescales, offering women screening on mobile vans, has
enabled the Primary Care Trusts the opportunity to promote breast
screening effectively to the eligible women who have failed to attend
their first appointment. In low-uptake areas, this has facilitated the
efforts to increase uptake to the national standard of 70%.
Reference
1. Quality Assurance Guidelines for Administrative and Clerical
Staff. NHSBSP Publication 47. Sheffield: NHS Breast
Screening Programme; 2000.
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Radial scars: to excise or not to excise?
A Moorhead, JE Murray, AM Gilchrist
South East Scotland Breast Screening Programme, Edinburgh, UK
Breast Cancer Res 2008, 10(Suppl 3):P63 (doi: 10.1186/bcr2061)
Radial scars present a difficult problem within breast screening. A
proportion contains a spectrum of pathological change, including
invasive cancer [1]. For this reason, surgical excision has been
recommended [1]. With increasing use of vacuum-assisted biopsy,
recommendations are now in place to allow leaving these lesions
without excision where no atypia is identified [2].
Breast Cancer Research    July 2008 Vol 10 Suppl 3 Symposium Mammographicum 2008
Table 1 (abstract P61)
Year 2004 2005 2006 2007
Number of mammograms 21 16 18 19
Number of MRI scans 1 10 11 12
MRI recalls 0 6 0 0
Cancer diagnosed 0 1 0 0S17
We present our series of 100 B3 radial scars consecutively
diagnosed by 14-gauge core biopsy between 2004 and 2007.
This includes 13 malignancies subsequently identified on surgical
excision. Five were invasive (size, 2 mm to 11 mm), and eight were
ductal carcinoma in situ (size, 3 mm to 22 mm). In three cases of
invasive cancer <10 mm, no concomitant atypia was identified. In
these cases, had vacuum-assisted biopsy not included the small
invasive area, surgical excision would not have been recommended
under current guidelines. Hence, the cancers would have remained
undetected.
This information will continue to inform the debate surrounding
surgical excision versus vacuum-assisted biopsy without excision
in the management of radial scars.
References
1. Sloane JP, Mayers MM: Carcinoma and atypical hyperplasia
in radial scars and complex sclerosing lesions. Histo-
pathology 1993, 23:225-231.
2. Clinical guidelines for breast cancer screening assess-
ment. 2nd edition. Unpublished work. January 2005.
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Infection control in the mammography units of New South
Wales, Australia and the Republic of Ireland
D O’Leary1, J McCrann1, A Poulos2, S Lewis2
1University College Dublin, Ireland; 2University of Sydney, New
South Wales, Australia
Breast Cancer Res 2008, 10(Suppl 3):P64 (doi: 10.1186/bcr2062)
Background  The goal of this research collaboration was to
establish whether mammography units within New South Wales,
Australia (NSW) and the Republic of Ireland (ROI) have dedicated
mammography-specific infection control protocols and the extent
of cleaning/disinfection of these units. Possible vectors for
increased bio-load on hospitals/outpatient facilities specifically due
to these mammography units were also examined. During
mammography, patients’ friable skin is in close contact with
equipment/hands; possibility of infection spread is highest where
immunity has been lowered by the disease process.
Method  A questionnaire underpinned by worldwide infection
control guidelines was formulated and circulated to radiographers
in symptomatic/asymptomatic mammography units within the ROI
and NSW.
Results Whilst mammography-specific infection control protocols
were available in fewer ROI units (25%) than NSW units (32%),
NSW mammographers (43%) had less access to documented
protocols (versus 94% for ROI units). Significant variation in
cleaning methods, consistency and procedures was observed in
both regions. Infection control is not routinely included in the
quality assurance process of all units.
Conclusion Many aspects of infection control procedures are less
than satisfactory. These procedures should be regulated with
specific mammography infection control protocols within the
quality assurance process to prevent patient cross-infection, with a
consequent lowering of biological burden on hospital/outpatient
facilities.
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diffusion-weighted magnetic resonance imaging (MRI) in
breast MRI at 3 T: is there a diagnostic value in
comparison with high temporal and spatial resolution
morphologic and dynamic MRI in patients with breast
lesions?
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Introduction  To assess the diagnostic accuracy of 1H-spectro-
scopic (3D-MRSI) and diffusion-weighted magnetic resonance
imaging (DWI) in comparison with high-temporal and spatial
resolution dynamic MRI in patients with breast lesions at 3 T.
Materials and methods Thirty-six patients were examined on a 3 T
system. The MRI protocol included: contrast-enhanced (CE)
coronal volumetric interpolated breathhold examination with high-
temporal resolution (isotropic 1.7 mm, time of acquisition (TA)
11.7 seconds, 17 measurements); coronal magnetization prepared
rapid gradient echo at expected maximum CE (1 mm isotropic, TA
2.03 minutes), repeated coronal volumetric interpolated breathhold
examination, diffusion-weighted imaging using a twice-refocused
singleshot echo planar imaging sequence with inversion recovery
fat-saturation employing four b values (TA 4.48 minutes), 3D-MRSI
(10 x 10 x 10 mm3; TA 11 minutes). The lesion morphology and
CE kinetics were assessed. Regions of interest for suspicious
areas were evaluated for elevated choline levels and decreased
apparent diffusion coefficient values as a marker of malignancy.
Results Sixty-five lesions were detected in 36 patients. CE-MRI
determined 11 lesions, DWI 11 lesions and 3D-MRSI 11 lesions
(one false positive, one false negative) as malignant. CE-MRI deter-
mined 48 lesions, DWI 54 lesions and 3D-MRSI 49 lesions as
benign. 3D-MRSI was not applicable in five prepectoral lesions.
CE-MRI determined six lesions as indifferent, which were benign
with DWI and 3D-MRSI.
Conclusion The performance of dynamic MRI and additional DWI
and 3D-MRSI is possible within reasonable scan time, and
additional DWI and 3D-MRSI aid the differentiation of breast
lesions with indifferent morphology and/or CE kinetics.
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premenopausal women in the Valencian Breast Cancer
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In 1992, the Valencian Breast Cancer Screening Program
(VBCSP) started in the Valencian Community. To date, 24
mammography units have been installed all over the region. There
is a health risk in the studied women that has to be estimated and
controlled. A methodology to calculate approximately the
radiological detriment in the VBCSP has been developed based on
Available online http://breast-cancer-research.com/supplements/10/S3S18
Monte Carlo techniques. As qualitative parameters in the program,
the average mean glandular doses from representative sample
populations undergoing screening mammography (digital or film)
from each of the 24 units in operation have been obtained. The
American College of Radiology Imaging Network reached the
conclusion that digital mammography performed significantly better
than film for premenopausal and perimenopausal women younger
than 50 years old [1]. Our group uses the software SCREENRISK
[2] to estimate the induction/detection rates in order to
corroborate American conclusions in a European region. The
obtained results confirm the American results about the application
of digital mammography in premenopausal and perimenopausal
women younger than 50 years old.
References
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Utilising cancer registration and screening data, every primary
breast cancer case diagnosed in women eligible for screening in
the West Midlands since screening began until March 2006 was
assigned a screening status based on the woman’s screening
history. Tumours were allocated to one of eight screening status
categories [1]. The 10-year relative survival was calculated for the
five main categories.
A total of 24,095 cancers were classified (Table 1). Of these,
27% were classified as interval cancers, and the incidence rates of
these cases were lower for the 25-month to 36-month period from
screening to diagnosis compared with the 0-month to 24-month
period. Of these interval cancers, 62% were diagnosed in women
who had been screened more than once. In the most affluent
women, 30% were interval cancers and 7% were non-attenders. In
the most deprived women, 21% were interval cancers and 15%
were non-attenders.
Women with screen-detected breast cancer had the best survival
rates; women with interval cancers had survival rates above those
of non-attenders, highlighting the benefits of screening.
Reference
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with the advent of Mammotome in the breast unit in
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Fibroadenomas are the commonest benign breast tumours. Prior to
vacuum-assisted large-volume biopsy, surgical excision was the
only therapeutic option available. Our unit introduced Mammotome
(Ethicon Endo-Surgery, Cincinnati, OH, USA) in January 2006,
with Mammotome excision offered from September 2006 (for
lesions 25 mm or less). We reviewed the change in practice with
the advent of Mammotome.
Patients with histological diagnosis of fibroadenoma throughout
2006 and 2007 were identified. The radiology and histology were
reviewed.
A total of 355 fibroadenomas were diagnosed in 333 patients: 252
presented symptomatically, 81 were screen-detected.
Thirty-five diagnostic Mammotomes were performed (33 had been
nondiagnostic on needle-core biopsy, two had radiology/pathology
discordance). Definitive diagnosis was consequently made in 34
cases. One patient with nondiagnostic Mammotome had subse-
quent surgical biopsy of benign fibroadenoma.
Seventy patients underwent excision. Fifteen were ultrasound
Mammotome excisions; 13 confirmed fibroadenoma and two were
phylloides (having surgical cavity excision subsequently). Fifty-five
were surgical excisions; 33 were either unsuitable for Mammotome
excision or the patient chose surgery; 11 were B2/B3 lesions and
pathology recommended surgical excision; and the remaining 11
were before the introduction of Mammotome excision.
Mammotome offers patient choice regarding excision of fibro-
adenomas, and reduces the number of surgical biopsies.
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Variations in excision biopsy rates for women with B3/C3
results do not account for high benign open biopsy rates in
the NHS Breast Screening Programme: a regional study
RM Watkins, F Johnson, A Mayer, A Bennett, DJ Harker, 
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South West Region NHSBSP QA Reference Centre, Bristol, UK
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Introduction Since 2000 the South West Region has shown a
benign open biopsy rate higher than the national average, often
failing to meet the guideline targets.
Methods Information from the nine screening units in the South
West Region of all women having a B3 or C3 diagnosis as their
final result following screening assessment during the period 2003
to 2005 was reviewed.
Results Of 374 women with a B3/C3 result, 89 (23%) had no
further investigations. Between individual units, the proportion of
women undergoing surgical biopsy ranged from 55% (18/33)
(95% CI = 37% to 71%) to 89% (72/81) (95% CI = 80% to
94%). Of 285 women undergoing open biopsy, 75 (26%) had
malignant disease. The range between units was 13% (5/38) to
36% (26/81). There was no correlation between the rate of open
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Table 1 (abstract P67)
Proportion 10-year  relative 
Screening status (%) survival rate (%)
Screen-detected 44 92.25
Interval 27 75.65
Diagnosed before invitation 12 68.81
Non-attender 9 53.95
Lapsed attender  4 72.15S19
biopsy for B3/C3 lesions and the overall benign biopsy rates,
which ranged from 0.76 to 2.74 per 1,000 women screened.
Conclusion  B3/C3 results following screening assessment are
associated with a significant risk of malignancy. Variations in rates
of surgical biopsy following an indeterminate result do not account
for differences in overall benign open biopsy rates. Further studies
are required to determine the indications for open biopsy in these
cases and to evaluate the outcome in women who do not undergo
open biopsy.
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The UK National Breast Screening Programme in Exeter has been
exclusively run by the National Health Service (NHS) since it
started in the early 1990s. The current medical climate is rapidly
undergoing change, with increasing utilisation of outsourcing to
independent providers. Certain domains, such as orthopaedics,
have a high usage of independent providers; however in other
domains, including breast radiology, the use is sparse.
Since 2005 the breast screening unit in Exeter has been privatised
to Lister-in-Health on a separate site, whilst the symptomatic and
surgical service has remained at the local hospital under the NHS.
We would like to discuss how there is continuity in the care
pathway for the screening patient, detailing how Lister Healthcare
interacts with the local hospital breast service; how patient
assessments and access to breast care nurses is carried out, and
the point at which a patient leaves the screening service to enter
the NHS treatment pathway. We also discuss the logistics of
communication between the screening radiologists and surgeons,
including discussion of histological findings, follow-up of
nonsurgical lesions, assessment of B3 lesions, multidisciplinary
teams and meetings.
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Guernsey provides healthcare for a population of 60,000. An on-
island breast screening programme has existed since March 1995,
with a 2-year screening round. Data have been analysed for six
screening rounds to the end of March 2007, and have been
evaluated against the National Health Service Breast Screening
Programme (NHSBSP) Pritchard Standards. The small cohort size
(<4,000 per annum) necessitates off-island screen reading by
NHSBSP readers. Assessments are performed in Guernsey by a
single breast radiologist. The majority of breast surgery is
performed in Guernsey.
Over the six screening rounds, a total of 39,166 screening
mammograms have been performed, 2,542 assessment visits have
been made, and 208 cancers have been identified (149 invasive,
59 ductal carcinoma in situ). Examples of standards evaluated for
the six rounds: compliance, >90%; standardised detection rate,
range 0.6 to 1.83; small cancer detection rates, 2.46/10,000
(average); interval cancers, 1.22 per 1,000 screened (average);
10-year survival from screen-detected cancers, 92%.
These data show an effective screening programme assessed by
Pritchard Standards, and demonstrate a model for the delivery of
breast screening in a small isolated population.
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Implementing barcode film-reading in the National Health
Service Breast Screening Programme: the good, the bad
and the ugly
ME Wheaton, K Stoddard
Coventry Breast Screening Training Centre, Coventry, UK
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The National Breast Screening Computer System (NBSS) was
redeveloped in 2003 and was rolled out to the programme during
2004. Following the national initiative to convert all breast screen-
ing programmes in England to use the NBSS system, barcode film-
reading functionality and the NBSS daybook software were
developed and piloted during 2005/06.
Although this functionality has been available now for nearly
3 years, services have been slow to implement this change for a
variety of reasons. Lack of funding for new hardware, inappropriate
accommodation, lack of space and a general unwillingness to
change have been sited as reasons for not implementing barcode
film-reading and/or the NBSS daybook.
The Coventry Breast Screening Training Centre has invested
considerable time with many breast screening services, helping
them implement this functionality. The Centre has helped services
adapt their processes to this new way of working whilst
maintaining the integrity of their Right Results procedure.
It is hoped that this practical guide will persuade the remaining
services to convert to this new functionality during 2008 and to
help those already using this functionality to overcome any issues.
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What makes a good mammographer? Looking at the
homogeneity of those groups who perform best and least
well on the PERFORMS self-assessment scheme
HJ Scott, AG Gale
Loughborough University, Loughborough, UK
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The Personal Performance in Mammographic Screening
(PERFORMS) scheme originated in 1991 and functions as a free
educational tool whereby film-readers routinely evaluate and
receive immediate and confidential feedback on 120 cases, bi-
yearly. In addition, most individuals complete a short questionnaire
describing real-life factors such as years of reading experience and
most typical screening practice (for example, reading duration,
frequency, and case volume). From these data we identified those
individuals who performed best (as a measure of excellence in film-
reading) and those who performed less well on PERFORMS with a
view to establishing a general film-reader profile. Previous research
has shown that individuals who read a lower volume of cases (for
example, new film-readers) may perform less well for sensitivity
measures. We also looked at occupational differences in these
profiles to determine whether radiologists and advanced
practitioners were significantly represented in either performance
group. We investigated low/high group profiles by analysing over
400 film-readers’ questionnaire/performance data for a recent
PERFORMS scheme. This analysis concentrated on possible
within-group similarities in style and manner of film-reading
according to self-report. We elucidate what characteristics and
practices, from self-report, are the most common for breast-
Available online http://breast-cancer-research.com/supplements/10/S3S20
screening film-readers within a high/low performance group, with a
view to possible training recommendations.
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Digital screening on a mobile unit: the Coventry experience
S Hoffmeister, A Stanton
University Hospitals Coventry & Warwickshire NHS Trust,
Coventry, UK
Breast Cancer Res 2008, 10(Suppl 3):P76 (doi: 10.1186/bcr2074)
Many National Health Service Breast Screening Programme
Screening Services are changing from analogue to digital
technology. Coventry was the first Screening Service to screen
digitally on a mobile unit. There are several factors that need to be
considered when planning to staff and equip a Full-field Digital
Mammography Breast Screening Service. In view of the planned
age expansion announced in the Cancer Reform Strategy, most
units will need to consider planning for these changes. These
considerations will include our local experience of drivers for
change, workforce planning, managing extended working days,
maintaining screening-round length, and some equipment issues.
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Managing interval cancers
J Hackney, L Chapman
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Breast Cancer Res 2008, 10(Suppl 3):P77 (doi: 10.1186/bcr2075)
The new National Health Service Breast Screening Programme
Interval Cancer Operational Manual (2008) has recently been
launched and is a practical guide for quality assurance reference
centres, cancer registries and breast screening units to record and
report interval cancers, with the aim of standardising practice
across the United Kingdom. Coventry has always been at the
forefront of this important work and, as part of the skill mix, the role
of collecting and reporting data has been taken on by radiography
film-readers. Coventry is the base for four different primary care
trusts and the film-readers have links with multidisciplinary team
meetings, breast care nurses, pathology and X-ray departments
from all these areas, and are also involved with symptomatic
mammography and local and regional interval cancer audits. The
present poster demonstrates the pathway taken to collect and
record information for audit and to forward it to the quality
assurance reference centre for regional and national review.
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Introduction SuperSonic Imagine has developed a unique
ultrasound platform that can image supersonic shear wave (SSW)
propagation and determine quantitative elastic properties of tissue.
The accuracy of this system’s elastography was evaluated with the
characterization of breast nodules.
Methods Thirty-six breast nodules (4 mm to 22 mm, 25 benign and
11 malignant; BI-RADS category 3 = six cases, category 4 = 21
cases, category 5 = seven cases and category 6 = two cases)
were prospectively evaluated in 34 patients (age 42 to 71 years;
mean age, 59 years). Radiohistological correlations were available
for all cases (fine-needle aspiration = 10 and/or core biopsies =
26). Data were processed to reconstruct the SSW colour images
and to obtain quantitative elasticity in kiloPascal units.
Results SSW elastography detected all breast nodules, and the
1 mm system resolution facilitated the detection of small or isoechoic
lesions. The mean elasticity of malignant lesions was significantly
higher than the mean value of benign lesions (170 ± 41.6 kPa
versus 62 ± 21 kPa). Owing to different displacement rates of
solid versus cystic material, this technique correctly characterized
the cystic component of complicated cysts in B-mode ultrasound.
Conclusion Quantitative SSW elastography allows a reliable,
reproducible and user-independent measurement of tissue elasticity,
thus providing a complementary tool for breast lesion diagnosis.
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Introduction  Mammography film-readers in the National Health
Service Breast Screening Programme are required to read 5,000
screening mammograms per year, and to participate in Personal
Performance in Mammographic Screening (PERFORMS). It is
known that individual cancer detection rates are higher when
individuals perform high volumes of breast imaging annually, and
that poor performance may be identified by PERFORMS. We have
looked more closely at details of reader performance to guide
individuals on how practice may be improved.
Method At our institution, films are double-read by radiologists and
advanced practitioners, with arbitration by consensus of two
readers. Information on 12 months of activity was obtained from
the National Breast Screening Service, and data on individual
workload, recall to arbitration rate, cancer detection rate and
cancers detected by only one reader were compared.
Results There is a weak association between the recall rate and the
cancer detection rate, and in general readers with high recall rates
miss fewer cancers. Overall the cancer detection rate is similar on
both first and second reads, although some readers perform best
on first read and others on second read. Feedback of these data
and discussion of arbitrary levels of preferred recall rates and
cancer detection rates is used to inform personal practice.
80
Lateral-approach stereotactic vacuum-assisted 10 G
breast biopsy using Vacora for indeterminate
microcalcifications: results of a single-institution
assessment of 172 procedures
EM Vanherreweghe, M Mortier, R Van den Broecke, 
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Objective  To report the results of Vacora biopsy under lateral-
approach stereotactic guidance.
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Methods  Two hundred and fifty procedures were performed in
249 consecutive patients. Specimens were sampled until at least
one contained microcalcifications. Surgery was performed when-
ever malignancy or borderline lesions were found (n = 114).
Normal results were mammographically followed up (n = 58). No
adequate follow-up was available for 78 procedures.
Results  An average of 4.6 specimens were sampled per
procedure. Cancer was diagnosed in 40% of cases: 9.4% invasive
ductal carcinomas, 1.2% invasive lobular carcinomas and 29.4%
intraductal carcinomas (ductal carcinoma in situ). Borderline
lesions were found in 6.1% of cases, mainly atypical ductal hyper-
plasia (5.7%). The remaining 53.9% of biopsies showed normal or
benign findings. The procedure was nondiagnostic in 2% of cases.
Vacora biopsy and subsequent surgery were concordant in 89.5%
of cases. In 10.5%, biopsy revealed ductal carcinoma in situ while
surgery proved invasive carcinoma. In 58 patients who were
mammographically followed-up for at least 6 months, no evolution
was detected.
Conclusion  Biopsy using Vacora under lateral-approach
stereotactic guidance is an easy and intuitive technique for
diagnosis of breast microcalcifications. An average of 4.6 speci-
mens per procedure is sufficient to sample representative
calcifications for reliable cancer diagnosis.
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older women: radiographers’ experiences of taking on a
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Introduction The London Psychosocial Group has been funded by
Cancer Research UK to implement and evaluate a psycho-
educational intervention to promote early presentation amongst
older women with breast cancer. The intervention is designed to
be radiographer-delivered to women receiving their final invited
mammogram with the National Health Service Breast Screening
Programme.
Objective To report the experiences of research radiographers in
delivering the 10-minute intervention to women in breast screening
clinics.
Methods Reflective diaries and supervision records were used to
collate the experiences of radiographers delivering the intervention
as part of a research trial and to discuss emerging issues and
challenges for widening the role of diagnostic radiographers
across the National Health Service.
Results The main challenges included learning and rehearsing a
structured interview, delivering complex health messages within
time constraints using behavioural change techniques, and dealing
with unexpected events, including emotional distress, during
interviews. Benefits included enhanced interaction with women
attending screening and extending the usual role of the
radiographer.
Conclusion It was beneficial yet demanding for radiographers to
extend their role in this way. Not all radiographers may be
motivated or suitable to undertake this work. Training and ongoing
supervision are essential to support radiographers who deliver the
intervention. 
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Does size matter? A review of screen-detected
microcalcifications seen at breast screening assessment
LIG Haigh
Breast Screening Unit, Leeds, UK
Breast Cancer Res 2008, 10(Suppl 3):P82 (doi: 10.1186/bcr2080)
A retrospective review was performed of 282 patients who were
recalled to the breast screening assessment clinic for further
evaluation of microcalcification over a 12-month period from 1 April
2005 to 31 March 2006.
Patients were subdivided into one of four groups according to the
size of the calcification cluster and the pathology was reviewed to
investigate the likelihood of diagnosing malignancy, either in situ or
invasive, with differing extents of radiological abnormality.
Further mammographic views were performed in all cases and
stereotactic core biopsy in 252 cases (89%). Thirty-one patients
were felt to either not be suitable for or not to need biopsy after
further mammography and were subsequently placed on early
clinic review or routine recall. Where the biopsy failed to obtain
calcification, the options of mammotome or early review were
considered at the multidisciplinary team meeting. A summary of the
findings is presented in Table 1.
Table 1 (abstract P82)
Number Ductal  carcinoma Invasive 
Size (mm) of cases in situ cancer
<5 64 8 (12.5%) 3 (4.6%)
6 to 10 77 14 (18.2%) 4 (5.2%)
11 to 15 28 1 (3.5%) 2 (7.1%)
>15 113 31 (27.4%) 21 (18.5%)
Small calcification clusters were often malignant (12.5% <5mm)
and included cases of invasive disease in 4.6%. They present a
diagnostic challenge in detection and management, but may
represent small invasive tumours.
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Imaging features of male breast cancer: a pictorial review
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Introduction Breast cancer in men is rare, accounting for less than
1% of all breast cancer cases. Presentation includes a lump, pain
and nipple discharge, and breast malignancy must be differentiated
from benign disease, particularly gynaecomastia. We have
diagnosed 17 men with breast cancer between 1998 and 2007.
Methods A retrospective review of imaging of men with
histologically proven breast cancer in 10 years.
Results The mean age at diagnosis was 63 years (range 38 to 87
years). Presentation was with a mass in 15 patients and with nipple
discharge in two patients. Eleven patients had mammography and
breast ultrasound (US). Mammography and US demonstrated a
mass in nine patients. The US lesions were echo-poor solid lesions
in eight patients and a mixed solid/cystic lesion in one patient.
Calcification and skin/nipple changes were each seen in five
cases. Mammogram demonstrated an asymmetric density in one
patient, and in this case US was normal. Bilateral gynaecomastia
was detected on mammogram and US in one patient. Histology in
14 patients demonstrated invasive ductal carcinoma with foci of
Available online http://breast-cancer-research.com/supplements/10/S3S22
ductal carcinoma in situ in six patients. Three patients had ductal
carcinoma in situ only.
Conclusion Male breast cancer most commonly manifests as a
discrete mass lesion on imaging, but radiologists need to be aware
of other imaging appearances. 
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Demonstrations of a prototype were used to elicit requirements for
a training system for screening mammography. The prototype
allowed mentors to select cases from a distributed image database
to meet the specific requirements of trainees. Trainees received
automated feedback in response to attempts at interpretation. The
prototype was demonstrated to radiologists and radiographers.
Comments were recorded and used to elaborate requirements for
a more sophisticated version.
The main classes of response were as follows: automated marking
and feedback – where the trainee’s interpretation did not match
the experts’ opinion exactly, the prototype acted is if the trainee
required correction, which was not always appropriate; integrating
with existing training practices – discussion between trainees and
mentors is important, and suggestions for supporting such
communication included providing comment facilities and the
ability to bookmark cases for further discussion; and searching and
browsing cases to build training sets – the provision for
constructing training sets appropriate for different teaching goals
is highly valued.
We are following an iterative process where requirements are
gathered, and prototypes are constructed, evaluated by users and
then refined until users are satisfied that their requirements have
been met. A new version of the tool has been developed.
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Mammographic interpretation training: what exactly do
film-readers want?
Y Chen, A Gale, H Scott
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The introduction of digital mammography opens up new
opportunities to provide a wide range of training to individuals
without the restriction of the mammographic multiviewer. Whilst
high-resolution monitors in an appropriate viewing environment are
de rigour for actual reporting of screening cases, the advantage of
the digital image over film is in the flexibility of training opportunity
afforded (for example, web-based training, or tailored training on
personal digital assistants). A previous study indicated the possible
potential for reporting mammographic cases utilising handheld
devices (providing suitable human–computer interaction tech-
niques are employed). The UK self-assessment scheme Personal
Performance in Mammographic Screening (PERFORMS) has also
identified where tailored training may be beneficial. Initially, groups
of mammographers were questioned in semistructured interviews
in order to help establish film-readers’ training preferences.
Content analysis revealed several main categories of training
issues, including requirements of individualised tailored training,
the location and timing of training opportunities, the ease of user
interaction and film-readers’ perspectives on the possible clinical
applicability of mobile devices. Subsequently, several breast
screening units completed a questionnaire concerning current and
anticipated training requirements. It is concluded that digital breast
imaging facilities tailored training for an individual that can be
achieved using mobile devices, and this is currently under
development.
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A review of breast cancers found in the Welsh Family
History screening programme
S Bolt, J Jones, M Rogers, J Evans, K Gower Thomas
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Mammographic screening for women at increased risk due to a
family history commenced in 2001 in Wales. Forty-one cancers
have been found, and 31 were screen detected. One-half were in
the high-risk category.
Of the high-risk cancers, 47% were grade 3 and 41% were node-
positive, despite annual screening. Ductal carcinoma in situ was
frequently found, and 75% of this was of high nuclear grade. In the
moderate-risk group there was an even spread of cancer grade,
fewer cases of ductal carcinoma in situ and no node-positive
tumours.
The most common mammographic findings were calcification and
glandular asymmetry.
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Common uses of immunohistochemistry in interpreting
lesions of the breast: a pictorial review
T Hoang1, R Rattan2
1Radiology Department, St George’s Hospital, London, UK;
2Cellular Pathology, St George’s Hospital, London, UK
Breast Cancer Res 2008, 10(Suppl 3):P87 (doi: 10.1186/bcr2085)
The present pictorial review includes a brief explanation of the
basic principles involved in immunohistochemistry and an overview
of its use as a problem-solving and prognostic tool in the context of
breast disease.
Myoepithelial markers cytokeratins 5/6, p63 and smooth muscle
actin are helpful in distinguishing lesions that mimic invasion,
namely radial scar and sclerosing adenosis from invasive lesions.
These markers can also be used in differentiating intraductal
papilloma from papillary carcinoma, and their patterns of
expression can help distinguish ductal carcinoma in situ from
atypical ductal hyperplasia. Epithelial markers such as AE1/AE3
and cytokeratin 7 may identify subtle foci of stromal invasion and
micrometastasis in lymph nodes. Each of the above scenarios is
illustrated with radiological and pathological images, and shows
the role of immunohistochemistry in attempting to resolve these
diagnostic dilemmas.
The role of this technique in the typing of certain breast tumours is
discussed and illustrated using E-cadherin in distinguishing ductal
from lobular carcinoma.
Finally, the prognostic role of immunohistochemistry in oestrogen
receptor, progesterone receptor and human epidermal growth
factor receptor 2 analysis for primary breast carcinomas is
illustrated.
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The scope for a rapid digitiser of mammograms and other
large-file, high-resolution images
R Grant, M Alsewan
Barking, Havering and Redbridge Hospitals NHS Trust, Romford,
UK
Breast Cancer Res 2008, 10(Suppl 3):P88 (doi: 10.1186/bcr2086)
A new high-speed, high-resolution digitiser has provided a facility
with which new means of communication and interaction become
possible.
1. The DicomNow Digitiser camera system will scan
mammography film at a 16-bit depth in less than 1 second.
2. The thresholds for compression of mammogram images have
previously been confirmed at a ratio between 65:1 and 80:1.
3. New opportunities for transmission between centres; difficult
analogue films can be digitised quickly, then compressed and
sent for consensus/arbitration views from an expert panel or
submitted to computer-aided diagnosis.
4. Applications to multidisciplinary team meetings in which all
types of images, patient information and pathology are shared
via any Internet link in a virtual meeting room.
5. The speed of DicomNow and the compression system
removes time limitations for telemedicine communication speeds
in mammography.
6. Archive potential to reduce storage cost and support disaster-
recovery initiatives.
7. Modular training programmes will benefit students with access
to high-resolution images via the scanning and compression
technology.
8. Higher level studies of subtle features of image interpretation
for validated case studies.
Each of these elements will be expanded to illustrate the effects of
high-speed digitising on breast cancer management.
Available online http://breast-cancer-research.com/supplements/10/S3